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Abstract
In a comprehensive cohort study of two competing treatments (say, A and B), clinically eligi-
ble individuals are first asked to enroll in a randomized trial and, if they refuse, are then asked
to enroll in a parallel observational study in which they can choose treatment according to their
own preference. We consider estimation of two estimands: (1) comprehensive cohort causal effect
– the difference in mean potential outcomes had all patients in the comprehensive cohort received
treatment A vs. treatment B and (2) randomized trial causal effect – the difference in mean poten-
tial outcomes had all patients enrolled in the randomized trial received treatment A vs. treatment
B. For each estimand, we consider inference under various sets of unconfoundedness assumptions
and construct semiparametric efficient and robust estimators. These estimators depend on nuisance
functions, which we estimate, for illustrative purposes, using generalized additive models. Using
the theory of sample splitting, we establish the asymptotic properties of our proposed estimators.
We also illustrate our methodology using data from the Bypass Angioplasty Revascularization In-
vestigation (BARI) randomized trial and observational registry to evaluate the effect of percutaneous
transluminal coronary balloon angioplasty versus coronary artery bypass grafting on 5-year mortal-
ity. To evaluate the finite sample performance of our estimators, we use the BARI dataset as the basis
of a realistic simulation study.
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1 Introduction
Randomized controlled trials (RCTs) are considered to be the gold standard for comparing treatments,
primarily because the experimental design probabilistically ensures that treatment groups are balanced
with respect to measured and unmeasured prognostic factors. A well conducted RCT is said to have
high internal validity. However, its external validity (i.e., generalizability of results to a broader popu-
lation) is not guaranteed. This is because eligible patients who agree to enroll in an RCT may be not
be a representative sample of all eligible patients. Due to the tension between internal and external
validity, researchers have recommended that all clinically eligible patients, agreeing to randomization
or not, should be enrolled and studied [Fielding et al., 1999].
Olschewski and Scheurlen [1985] introduced the comprehensive cohort study (CCS) design for eval-
uating competing treatments (say, A and B) in which clinically eligible participants are first asked to
enroll in a randomized trial and, if they refuse, are then asked to enroll in a parallel observational study
(OBS) in which they can choose treatment according to their own preference.
Most of the literature that describes methods for analyzing data from a CCS has focused on esti-
mating treatment effects separately for the RCT and OBS (e.g., Olschewski et al. [1992], Henshaw et al.
[1993], Nicolaides et al. [1994], Schmoor et al. [1996], King et al. [1997], Detre et al. [1999], Bedi et al.
[2000], Brooks et al. [2000], Kerry et al. [2000], King et al. [2000], Rovers et al. [2001], Jensen et al. [2003],
Schmoor et al. [2008]), with some adjustment for confounding in the OBS. With the exception of
Olschewski et al. [1992], King et al. [1997] and Brooks et al. [2000], there is no borrowing of information
between the RCT and OBS.
Here, we focus on drawing causal inferences about treatment effects from a CCS, where the primary
outcome (continuous or binary) is to be measured at a fixed point in time after treatment assignment.
We are interested in drawing inference about two causal estimands: comprehensive cohort causal effect –
the difference in mean potential outcomes had all patients in the CCS received treatment A vs. treat-
ment B, and randomized trial causal effect – the difference in mean potential outcomes had all patients
enrolled in the RCT received treatment A vs. treatment B. The comprehensive cohort causal effect is of
interest because it refers to a broader population of eligible patients than those willing to participate
in the randomized trial. The randomized trial causal effect is of interest because it is defined experi-
mentally and its estimates would more confidently generalize to future patients with covariate profiles
similar to those in the RCT.
The paper is organized as follows. In Section 2, we introduce notation, data structure, and main
assumptions. Sections 3.2 and 3.3 present estimators and their properties for the comprehensive cohort
causal effect and randomized trial causal effect, respectively. In Section 4, we illustrate our methods
using data from the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial and
observational registry to evaluate the effect of percutaneous transluminal coronary balloon angioplasty
(PTCA) versus coronary artery bypass grafting (CABG) on 5-year mortality. Section D presents a
simulation study, motivated by the BARI study, that evaluates the performance of our estimators. The
last section is devoted to a discussion.
2 Notation and framework
Let X denote a vector of baseline covariates and let Y be the observed outcome (continuous or binary).
Let R denote the randomization consent indicator (1 for RCT, 0 for OBS) and let T denote the treatment
assignment indicator (1 for treatment A, 0 for treatment B). The observed data for an individual are O =
(X′,Y, R, T)′. We assume n independent and identically distributed copies of O are drawn from some
distribution P∗ contained inM. Throughout, the superscript ∗ will be used to denote the true value of
the quantity to which it is appended. The subscript i will denote data associated with individual i.
Let Y1,r and Y0,r be an eligible patient’s potential outcome under treatment A and B, respectively,
when enrolled into study r (r = 1 for RCT and r = 0 for OBS). We assume there is a single version of
treatment (i.e., Yt,1 = Yt,0 = Yt for t = 0, 1; VanderWeele [2009]).
Letting ν∗t = E[Yt|R = 1], the randomized trial causal effect is defined as ∆RCT = ν∗1 − ν∗0 . Letting
µ∗t = E[Yt], the comprehensive causal effect is defined as ∆CC = µ∗1 − µ∗0. Our goal is to draw inference
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Table 1: Notation
Symbol Description (t = 0, 1)
R Randomization consent indicator (1 for RCT, 0 for OBS)
T Treatment indicator (1 for A, 0 for B)
X Baseline covariates
Yt Potential outcome under treatment t
Y Observed outcome
µ∗t E[Yt]
∆CC µ
∗
1 − µ∗0
ν∗t E[Yt|R = 1]
∆RCT ν
∗
1 − ν∗0
τ∗t (r, x) E[Yt|R = r,X = x]
(A1,A2)
= E[Y|T = t, R = r,X = x]
τ∗t (x) E[Yt|X = x]
(A3)
= τ∗t (r, x)
(A1,A2,A3)
= E[Y|T = t,X = x]
∆∗CC µ
∗
1 − µ∗0
∆∗RCT ν
∗
1 − ν∗0
λ∗r P[R = r]
λ∗r (x) P[R = r|X = x]
π∗t (r, x) P[T = t|R = r,X = x]
π∗t (x) P[T = t|X = x] = πt(1, x)λ∗1(x) + πt(0, x)λ∗0(x)
π∗t1 P
[
T = t|R = 1] (A1)= π∗t (1, x)
about ∆RCT and ∆CC.
To identify these causal effects from the observed data, we posit assumptions sufficient for identifi-
cation of ν∗t and µ∗t (t = 0, 1). We make the no interference assumption so that the potential outcomes of an
individual are unaffected by the randomization consent and treatment decision of any other individual
[Cox, 1958]. We make the consistency assumption that connects the observed outcomes to the potential
outcomes via the following relation: Y = TY1 + (1− T)Y0 [VanderWeele, 2009]. In addition, we will
utilize assumptions from among the following:
(A1) In the RCT, treatment is randomized: T⊥ (Y1,Y0,X)
∣∣ R = 1
(A2) In the OBS, treatment is randomized within levels of X: T⊥ (Y1,Y0)
∣∣ R = 0,X
(A3) Consent into the RCT is randomized within levels of X: R⊥ (Y1,Y0)
∣∣X
(A1) and (A2) indicate that, conditional on (X,Y1,Y0, R), treatment selection is a Bernoulli process with
probability π∗t (r, x) = P
[
T = t|R = r,X = x]. Note that (A1) implies that π∗t (1, x) does not depend on
x. Letting π∗t1 = π
∗
t (1, x) be the known randomization probability, we have that π
∗
t (r, x) = rπ
∗
t1 + (1−
r)π∗t (0, x). We let λ∗1(x) = P[R = 1|X = x]. We further impose positivity conditions so 0 < λ∗1(x) < 1
and 0 < π∗1(r, x) < 1 for all x and r = 0, 1 [Herna´n and Robins, 2006]. We assume the first and second
moments of the conditional distribution of Yt given R = r and X = x are finite for all x and r, t = 0, 1.
We define τ∗t (r, x) = E[Yt|R = r,X = x] and τ∗t (x) = E[Yt|X = x]. Note that under (A1) and (A2),
τ∗t (r, x) = E[Y|T = t, R = r,X = x]. Under (A3), τ∗t (r, x) = τ∗t (x). For convenience, Table 1 provides a
complete list of our notation.
We consider inference about the comprehensive cohort causal effect under (A1) and (A2), under
(A1) and (A3), and under (A1), (A2) and (A3), and inference about the randomized trial causal effect
under (A1) and under (A1), (A2) and (A3). The two parameters will be equal if the causal effect in the
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Figure 1: Directed acyclic graphs representing various assumptions. The dashed arrows in the figures
indicate absence when R = 1 and presence when R = 0. Dashed nodes represent random variables
that are unobserved (U) or potential outcomes (Y1,Y0).
OBS is equal to the causal effect in the RCT. This will occur when (A3) holds and either (i) the distribu-
tion of covariates is the same in the OBS and the RCT or (ii) there is no treatment effect heterogeneity.
In this paper, we derive, using semiparametric theory [Tsiatis, 2006, Van der Laan and Robins, 2003,
Bickel et al., 1993], efficient and robust estimators of these causal effects under these sets of assump-
tions.
Marcus [1997] discussed assumptions similar to (A1) to (A3) for identifying the comprehensive
cohort causal effect. The author discussed how unbiased estimates of the comprehensive cohort causal
effect can be obtained using outcome/treatment/covariate data from RCT only, OBS only as well as the
entire CCS. Our proposed estimator of the comprehensive causal effect under (A1) and (A2) and under
(A1), (A2) and (A3) uses outcome/treatment/covariate data from the entire CCS and, under (A1) and
(A3), uses outcome/treatment/covariate data from just the RCT.
Estimation of the randomized trial causal effect under (A1), (A2) and (A3) uses outcome/treatment/covariate
data from the entire CCS. Conceptually, one can think of our approach as using data from the OBS to
emulate the RCT [Herna´n et al., 2008] and combining the resulting estimate with the estimate that uses
RCT data only. If (A2) and (A3) are correct, we will have a more precise estimate of the randomized
trial causal effect, but if the assumptions are wrong then the estimate may be biased. This bias-variance
tradeoff may be appropriate in the setting of under-powered randomized trials.
Figure 1 presents directed acyclic graphs (DAGs) that represents various combinations of assump-
tions. The dashed arrows in the figures indicate absence when R = 1 and presence when R = 0.
Importantly, DAG (c), which encodes (A1), (A2) and (A3), induces testable restrictions, above and be-
yond (A1), on the distribution of the observed data; it implies that Y is independent of R given T and X.
This holds because all paths from R to Y are blocked by T and X, which are non-colliders. Assuming
(A1) holds, (A2) and (A3) can be tested by checking whether there is difference between the distribution
of the observed outcome between those enrolled in the RCT and those enrolled in the OBS, after ad-
justing for treatment and covariates. If there is evidence of a difference, we cannot, unfortunately, tease
out which of the two assumptions is misspecified. Note that the conditional independence statement
does not hold in DAG (a) because of the unblocked paths R ← U → Yt → Y, t = 0, 1, and in DAG (b)
because of the paths R→ T ← U → Yt → Y, t = 0, 1, with the conditioning variable T being a collider.
3 Inference
3.1 Semiparametric Theory and Inferential Strategy
Under assumptions, the target parameters µ∗t and νt∗ can be written as functionals of the distribution of
the observed data P∗. Abstractly, define the functional by ψ(·) : M→ R, with true value ψ∗ = ψ(P∗).
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For sufficiently smooth functionals like those considered in this paper, it can be shown that
ψ(P)− ψ(P∗) =
∫
G(P)(o)d(P− P∗)(o) + Rem(P, P∗) (1)
where (1) G is an analytic object depending on P and observation value o with EP[G(P)(O)] =∫
G(P)(o)dP(o) = 0 and VarP[G(P)(O)] =
∫
G(P)(o)2dP(o) < ∞ and (2) Rem(P, P∗) is a ”second-
order” remainder term that involves products of differences between P and P∗ (or their components)
and tends to zero as P tends to P∗. The object G can be viewed as a “gradient” as it measures, at any
given data-generating distribution P, the change in ψ(P) following a slight perturbation of P. Equation
(1) is called a von Mises expansion, a distributional version of a Taylor expansion [Bickel et al., 1993,
Carone et al., 2014, Robins et al., 2017].
Provided (1) holds and for a given estimator P̂ of P∗,
ψ(P̂)− ψ(P∗) = −
∫
G(P̂)(o)dP∗(o)︸ ︷︷ ︸
Bias
+Rem(P̂, P∗), (2)
where the first term on the right hand side represents the bias of the plug-in estimator. One way
to estimate the bias is by − ∫ G(P̂)(o)dPn(o), where Pn denotes the empirical distribution based on
O1,O2, . . . ,On, to produce the corrected plug-in or one-step estimator
ψ̂ = ψ(P̂) +
∫
G(P̂)(o)dPn(o).
This estimator “uses the same data twice” and asymptotic theory will require the imposition of poten-
tially restrictive Donkser conditions [Van der Vaart, 2000].
An alternative approach that works under weaker conditions is sample splitting [Chernozhukov et al.,
2017, Robins et al., 2008, Zheng and van der Laan, 2010]. The idea is to randomly split the observed
data into K (approximately) equally-sized disjoint sets. Let Si be the split membership of the ith obser-
vation (i.e, Si ∈ {1, . . . ,K}). Let Pˆ(−k) be the estimator of P∗ based on all the observed data except that
of kth split, P
(k)
nk be the empirical distribution based on the nk (≈ n/K) observations in the kth split, and
ψ̂(k) = ψ(P̂(−k)) +
∫
G(P̂(−k))(o)dP(k)nk (o).
The sample splitting estimator of ψ∗ is ψ˜ = 1K ∑
K
k=1 ψ̂
(k). To understand the behavior of this estimator,
we can write ψ˜− ψ∗ as
1
K
K
∑
k=1

1
nk
∑
Si=k
G(P∗)(Oi) +
∫ {
G(P̂(−k))(o)− G(P∗)(o)
}
d(P
(k)
nk − P∗)(o)︸ ︷︷ ︸
Term R1k
+ Rem(P̂(−k), P∗)︸ ︷︷ ︸
Term R2k

Using the sample splitting lemma of Kennedy et al. [2018],
√
nkR1k will be
OP∗
(∥∥∥G(P̂(−k))− G(P∗)∥∥∥
L2
)
, where
∥∥ f∥∥
L2
=
√
E∗[ f (O)2]. If
∥∥∥G(P̂(−k))− G(P∗)∥∥∥
L2
converges in prob-
ability to zero (Regularity Condition 1), then
√
nkR1k will be oP∗(1). Further, if P̂
(−k) is a sufficiently
well-behaved estimator of P∗ (i.e., converges at rates faster than n1/4) and R2k is second-order (Regu-
larity Condition 2), then
√
nkR2k will be oP∗(1). With nk = n/K,
√
n(ψ˜− ψ∗) = 1√
n
n
∑
i=1
G(P∗)(Oi) +
1√
K
K
∑
k=1
√
nkRk︸ ︷︷ ︸
oP∗ (1)
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where Rk = R1k + R2k. Note that the second term on the right hand side will be oP∗(1) since it is a finite
sum of oP∗(1) terms times a constant. The first term on the right hand side will converge in distribution,
by the central limit theorem for i.i.d. data, to a normal random variable with mean zero and variance
E[G(P∗)(O)2]. This shows that ψ˜ is asymptotically linear with influence function G(P∗)(O). The
asymptotic variance of ψ˜ can be estimated by 1n ∑
K
k=1 ∑i:Si=k G(P̂
(−k))(Oi)2. Importantly, Equation (1)
coupled with the asymptotically linearity of ψ˜ will imply (under mild regularity conditions) that ψ˜ is a
”regular” [Newey, 1990].
Although there may be many choices of G that satisfy (1), efficiency theory motivates the use of
the canonical gradient, often called the efficient influence function, in the construction of the above
estimator. The resulting estimator is then not only asymptotically linear but also asymptotically efficient
relative to model M . The canonical gradient can be obtained by projecting any other gradient onto the
tangent space, defined at each P ∈ M as the closure of the linear span of all score functions of regular
one-dimensional parametric models through P. A comprehensive treatment of efficiency theory can be
found in Pfanzagl [1982] and Bickel et al. [1993].
The model M will be characterized by all distributions that satisfy the specified identification as-
sumptions. Depending on the estimand and assumptions, the efficient influence curve will depend on
P∗ through a subset of π∗t1 (known), λ
∗
1, λ
∗
1(X), π
∗
t (0,X), τ
∗
t (X), τ
∗
t (1,X), τ
∗
t (0,X). The parameter λ
∗
1 is
estimable at n1/2 rates by λ̂1 = ∑i Ri/n. In order to estimate the functions of X at fast enough rates, we
will model them using generalized additive models (GAMs) in our simulations and application. We
also use the rates of convergence for (GAMs) to illustrate our theoretical results. However, any desired
method can be used as long as it provides the required rates of convergence. It is important to note that
these models will induce a model for π∗t (X), since π∗t (X) = λ∗1(X)π
∗
t1 + (1− λ∗1(X))π∗t (0,X). Under
appropriate smoothness conditions (i.e., the functions of the continuous variables in the generalized ad-
ditive models have two derivatives), the parameters of the models for λ∗1(X), π
∗
t (0,X), τ
∗
t (X), τ
∗
t (1,X),
and τ∗t (0,X) (and thus, π∗t (X)) will be estimable at n2/5 rates [Horowitz, 2009]. Where appropriate, we
will comment on robustness of our estimators to model misspecification.
We will use semiparametric theory to compute the most efficient influence function in model M
and use this to motivate the construction of asymptotically linear (AL) estimators µ∗t and ν∗t . Then ∆∗CC
and ∆∗RCT can be estimated by the corresponding linear combinations of estimators for µ
∗
1 , µ
∗
0, ν
∗
1 and
ν∗0 ; linear combinations of AL estimators are AL. The key elements of the proofs of the theorems that
appear in the next two subsections can be found in the Appendix.
3.2 Comprehensive Cohort Causal Effect
Theorem 1 Under (A1) and (A2), µ∗t is identified via the following formulae:
µ∗t = E
∗
[
I(T = t)Y
π∗t (R,X)
]
= E∗[τ∗t (R,X)]
The optimal influence function for µ∗t is
G
(A1,A2)
µt∗ (P
∗)(O) =
I(T = t)Y
π∗t (R,X)
+
{
1− I(T = t)
π∗t (R,X)
}
τ∗t (R,X)− µ∗t . (3)
The influence function G
(A1,A2)
µt∗ (P∗)(O) and resulting split-sampling estimator µ˜
(A1,A2)
t have the following prop-
erties:
• G(A1,A2)µt∗ (P∗)(O) is robust in the sense that it is mean zero if (i) τ∗t (0,X) is replaced by any τ†t (0,X) or
(ii) π∗t (0,X) is replaced by any π†t (0,X); it has mean zero if τ∗t (1,X) is replaced by any τ†t (1,X);
• µ˜(A1,A2)t will be consistent provided the models for τ∗t (0,X) or the model for π∗t (0,X) is correctly specified;
the model for τ∗t (1,X) need not be correctly specified;
• Under correct specification of models for τ∗t (0,X) and π∗t (0,X) and a possibly misspecified model for
τ∗t (1,X), µ˜
(A1,A2)
t will be regular and asymptotically linear with influence function G
(A1,A2)
µt∗ (P∗†)(O),
6
where P∗† is the true distribution of the observed data with τ∗t (1,X) replaced with τ†(1,X) (asymptotic
limit of τ̂
(−k)
t (1,X)).
The estimator µ˜
(A1,A2)
t uses treatment, outcome and covariate data from the entire CCS. The influ-
ence function is similar to the one discussed by Scharfstein et al. [1999], Bang and Robins [2005] and
Funk et al. [2011].
Theorem 2 Under (A1) and (A3), µt∗ is identified via the following formulae:
µ∗t = E
∗
[
RI(T = t)Y
λ∗1(X)π
∗
t1
]
= E∗[τ∗t (1,X)]
The optimal influence function for µ∗t is
G
(A1,A3)
µt∗ (P
∗)(O) =
RI(T = t)Y
λ∗1(X)π
∗
t1
+
{
1− RI(T = t)
λ∗1(X)π
∗
t1
}
τ∗t (1,X)− µ∗t (4)
The influence function G
(A1,A3)
µt∗ (P∗)(O) and resulting split-sampling estimator µ˜
(A1,A3)
t have the following prop-
erties:
• G(A1,A3)µt∗ (P∗)(O) is doubly robust in the sense that it is mean zero even if (i) λ∗1(X) is replaced by any
λ†1(X) or (ii) τ
∗
t (1,X) is replaced by any τ
†
t (1,X);
• µ˜(A1,A3)t is consistent provided the model for λ∗1(X) or the model for τ∗t (1,X) is correctly specified;
• Under correct specification of models for λ∗1(X) and τ∗t (1,X), µ˜(A1,A3)t will be regular and asymptotically
linear with influence function G
(A1,A3)
µt∗ (P∗)(O).
The estimator µ˜
(A1,A3)
t uses treatment/outcome/covariate data for all individuals in the RCT and co-
variate data for individuals in the OBS. The influence function is similar to the one discussed by
Dahabreh et al. [2018].
Theorem 3 Under (A1), (A2) and (A3), µt∗ is identified via the following formulae:
µ∗t = E
∗
[
I(T = t)Y
π∗t (X)
]
= E∗[τ∗t (X)]
The optimal influence function for µ∗t is
G
(A1,A2,A3)
µt∗ (P
∗)(O) =
I(T = t)Y
π∗t (X)
+
{
1− I(T = t)
π∗t (X)
}
τ∗t (X)− µ∗t (5)
The influence function G
(A1,A2,A3)
µt∗ (P∗)(O) and resulting split-sampling estimator µ˜
(A1,A2,A3)
t have the following
properties:
• G(A1,A2,A3)µt∗ (P∗)(O) is doubly robust in the sense that it is mean zero even if (i) π∗t (X) is replaced by any
π†t (X) or (ii) τ
∗
t (X) is replaced by any τ
†
t (X);
• µ˜(A1,A2,A3)t is consistent provided the model for π∗t (X) or the model for τ∗t (X) is correctly specified;
• Under correct specification of models for π∗t (X) and τ∗t (X), µ˜(A1,A2,A3)t will be regular and asymptotically
linear with influence function G
(A1,A2,A3)
µt∗ (P∗)(O).
The estimator µ˜
(A1,A2,A3)
t , uses treatment, outcome and covariate data from the entire CCS. Under
Assumptions (A1), (A2) and (A3) and correct model specification, µ˜
(A1,A2,A3)
t will be as or more efficient
than µ˜
(A1,A2)
t and µ˜
(A1,A3)
t .
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3.3 Randomized Trial Causal Effect
Theorem 4 Under (A1), ν∗t is identified via the following formulae:
ν∗t = E
∗
[
RI(T = t)Y
λ∗1π
∗
t1
]
= E∗
[
Rτ∗t (1,X)
λ∗1
]
The optimal influence function for ν∗t is
G
(A1)
νt∗ (P
∗)(O) =
R
λ∗1
 I(T = t)Yπ∗t1 +
{
1− I(T = t)
π∗t1
}
τ∗t (1,X)− ν∗t
 (6)
The influence function G
(A1)
νt∗ (P∗)(O) and resulting split-sampling estimator ν˜
(A1)
t have the following properties:
• G(A1)νt∗ (P∗)(O) is robust in the sense that it has mean zero even if τ∗t (1,X) is replaced by τ†t (1,X).
• ν˜(A1)t will be consistent even if the model for τ∗t (1,X) is incorrectly specified.
• Under a possibly misspecified model for τ∗t (1,X), ν˜(A1)t will be regular and asymptotically linear with
influence function G
(A1)
νt∗ (P∗†)(O), where P∗† is the true distribution of the observed data with τ∗t (1,X)
replaced with τ†(1,X) (asymptotic limit of τ̂
(−k)
t (1,X)).
The estimator ν˜
(A1)
t uses treatment/outcome/covariate data for all individuals in the RCT. It will be
consistent even if the model for τ∗t (1,X) is incorrectly specified. The influence function is the same as
that discussed in Chapter 13 of Tsiatis [2006]. Imposing either (A2) or (A3), above and beyond (A1),
does not result in any efficiency improvement.
Theorem 5 Under (A1), (A2) and (A3), ν∗t is identified via the following formulae:
ν∗t = E
∗
[
I(T = t)λ∗1(X)Y
λ∗1π
∗
t (X)
]
= E∗
[
λ∗1(X)τ
∗
t (X)
λ∗1
]
The optimal influence function for ν∗t is
G
(A1,A2,A3)
νt∗ (P
∗)(O) =
I(T = t)λ∗1(X)Y
λ∗1π
∗
t (X)
+
{
R− I(T = t)λ
∗
1(X)
π∗t (X)
}
τ∗t (X)
λ∗1
− R
λ∗1
ν∗t (7)
The influence function G
(A1,A2,A3)
νt∗ (P∗)(O) and resulting split-sampling estimator ν˜
(A1,A2,A3)
t have the following
properties:
• G(A1,A2,A3)νt∗ (P∗)(O) is robust in the sense that it has mean zero even if (i) τ∗t (X) is replaced by τ∗t (X) or
(ii) δ∗(X) = (λ∗1(X),π
∗
t (0,X)) is replaced by δ
†
t (X) 6= δ∗t (X).
• ν˜(A1,A2,A3)t will be consistent provided the model for τ∗t (X) is correctly specified or the models for λ∗1(X)
and π∗t (0,X) are correctly specified.
• Under correct specification of models for π∗t (X) and τ∗t (X), ν˜(A1,A2,A3)t will be regular and asymptotically
linear with influence function G
(A1,A2,A3)
νt∗ (P∗)(O).
The estimator ν˜
(A1,A2,A3)
t uses treatment/outcome/covariate data from the entire CCS.
8
3.4 Remarks:
Although the estimators µ˜
(A1,A2)
t , µ˜
(A1,A3)
t and ν˜
(A1,A2,A3)
t are doubly robust with respect to consistency,
achieving doubly robust inference (i.e., constructing confidence intervals with nominal coverage even
if one of the modeling conditions is misspecified) is not straightforward in nonparametric settings.
We refer to Van der Laan [2014] and Benkeser et al. [2017] for recent progress on this problem. An
alternative would be to use parametric models, for which the contribution to the variance is more
straightforward to derive under misspecification. Although this would allow doubly robust inference,
it would come at the cost of making much more restrictive assumptions on the nuisance functions. Since
our approach only requires relatively slow second-order rate conditions (e.g., n1/4+ǫ rates), the nuisance
functions can be modeled flexibly, thereby reducing the risk of misspecification (making doubly robust
inference a less crucial goal).
4 Analysis of BARI
BARI was designed to compare survival in patients receiving either PTCA or CABG. As summarized in
Brooks et al. [2000], a comprehensive cohort design was adopted and included 3,839 patients who had
severe angina or ischemia and multivessel coronary artery disease suitable for initial revascularization
by either PTCA or CABG, and who were willing to be followed up. Among these patients, 1,829 patients
consented to randomization and entered a randomized trial. The remaining 2,010 patients refused
randomization but agreed to participate in the BARI registry, in which patients could choose their
initial treatment in consultation with their physician. The follow-up plan was similar for randomized
(RCT) and registry (OBS) patients.
In our re-analysis of the BARI study, we excluded 196 registry patients who did not receive treat-
ment within 3 months of study entry as well as 33 RCT patients who did not receive their assigned
treatment. Our analysis utilized information on 12 baseline variables: age, sex, highest level of ed-
ucation, systolic blood pressure, diastolic blood pressure, qualifying symptoms (unstable angina/MI
vs. other), number of diseased vessels (three vs. less than three), proximal left anterior descending
disease, prior myocardial infarction, diabetes (no, with treatment, without treatment), current smoking,
hypertension. All variables are categorical except age, systolic blood pressure and diastolic blood pres-
sure which are continuous. Patients missing at least one of these covariates (n = 149) were excluded.
Finally, four patients with less than five years of follow-up and known to be alive at last follow-up were
excluded. Thus, our analysis included data on 3,457 patients (1,695 from OBS and 1,762 from RCT).
Among RCT patients, 888 (50.4%) received PTCA and among OBS patients, 1,108 (65.4%) chose and
received PTCA.
Table 2 presents the baseline characteristics of patients, stratified by study type and treatment. The
table shows that, in aggregate, patients who enrolled in the RCT tended to be slightly sicker than
those who enrolled in the OBS. Further stratifying by treatment group reveals more stark differences
between RCT and OBS patients, especially with respect to number of diseased vessels and proximal left
anterior descending disease. Since consenting to participate in an RCT is a personal patient decision,
it is possible that there may be differences between RCT and OBS patients with respect to unmeasured
factors such as self-efficacy and health behaviors (i.e., (A3) may be violated). Within the RCT, the two
treatments were well balanced with respect to the baseline factors. Within the OBS, we see that CABG
patients tend to have more severe disease than PTCA patients. Within the OBS, the selection of PTCA as
compared to CABG is largely based on the patients’ coronary anatomy and symptoms. Physicians play
a critical role in advising patients regarding procedure selection, and physician decisions are generally
based on objective clinical and angiographic criteria. It is therefore plausible that we have accounted for
the most important prognostic factors that are related to treatment selection within the OBS (i.e., (A2)
is reasonable). In the RCT, the proportion of patients who died by five years was 13.40% and 10.30%
in the PTCA and CABG arms, respectively. In the OBS, the death rate was uniformly lower with 7.94%
and 8.86% of PTCA and CABG patients dying, respectively.
In our analysis, R denotes the randomization consent indicator, T denotes the indicator of receiving
PTCA, Y denotes the indicator of death by the end of 5 years and X is the vector of baseline variables.
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Table 2: Baseline characteristics of the BARI study participants
RCT OBS
Total PTCA CBAG Total PTCA CBAG
n 1762 888 874 1695 1108 587
Age (Mean) 60.91 61.20 60.62 60.97 60.47 61.90
Male (%) 73.21 72.52 73.91 74.61 74.19 74.11
Highest Education Level
High School (%) 50.45 50.11 50.80 47.55 46.39 49.74
Some College (%) 18.10 17.91 18.31 20.24 20.67 19.42
College/Professional (%) 10.56 11.04 10.07 21.00 21.12 20.78
SBP (Mean) 129.78 128.55 131.02 129.79 129.12 131.05
DBP (Mean) 75.93 75.27 76.59 75.68 75.42 76.19
Qualifying Symptoms
Unstable Angina/MI 68.39 67.00 69.79 68.38 67.24 70.53
Three Diseased Vessels (%) 39.56 38.29 40.85 36.99 29.69 50.77
Proximal Left Anterior
Descending Disease 40.24 40.65 39.82 36.58 31.50 46.17
Prior Myocardial Infarction 54.26 53.49 55.03 50.03 49.91 50.26
History of Diabetes
With Treatment (%) 19.01 18.58 19.45 16.81 15.52 19.25
Without Treatment (%) 4.94 5.07 4.81 4.60 4.15 5.45
Current Smoking (%) 25.43 26.35 24.49 20.83 23.01 16.70
Hypertension (%) 48.64 48.87 48.40 48.02 45.84 52.13
We evaluated (A2) and (A3) by fitting, separately by treatment group, a generalized additive logistic
regression model for the probability of dying by the end of 5 years as a function of the randomization
consent indicator, the categorical variables (treated as factors) as well as smooth functions of age,
systolic blood pressure and diastolic blood pressure. In the PTCA model, the estimated conditional
odds ratio of dying for patients enrolled in the RCT versus OBS was 1.68 (95% CI: 1.09 to 2.58) providing
statistical evidence against (A2) and (A3). In the CABG model, the estimated conditional odds ratio
of dying for patients enrolled in the RCT versus OBS was 1.13 (95%: 0.66 to 1.96), yielding equivocal
evidence against (A2) and (A3).
Despite evidence against (A2) and (A3), we proceeded, for illustrative purposes, to estimate µ∗t and
ν∗t under various combinations of assumptions. Towards this end, we fit generalized additive logistic
regression models for λ∗1(X), π
∗
1(0,X), τ
∗
1 (X), τ
∗
0 (X), τ
∗
1 (1,X), τ
∗
0 (1,X), τ
∗
1 (0,X), and τ
∗
0 (0,X). Our
sample splitting estimators were based on K = 5 splits. Table 3 displays the estimated comprehensive
cohort and randomized trial causal effects (along with standard errors and 95% Wald-based confidence
intervals) under the different assumptions.
For the comprehensive cohort causal effect, the estimator under (A1) and (A2) has greater precision
than that under (A1) and (A3). Comparatively speaking, the latter estimator is further from the null
with an associated 95% confidence interval that excludes the null. The estimator that imposes all
three assumptions was closer to the estimator under (A1) and (A2) than under (A1) and (A3). For
the randomized trial causal effect, the estimator under (A1), (A2) and (A3) has, as expected, greater
precision than that under (A1). The former estimator is further from the null, with a 95% confidence
interval that excludes the null. Given the evidence against (A2) and (A3) in the PTCA arm, the only
trustworthy estimator is the randomized trial causal effect. Thus, our analysis cannot provide evidence
that effect seen in the RCT generalizes to the entire cohort. Our findings are largely consistent with the
findings of BARI Investigators [1996] and Feit et al. [2000].
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Table 3: Comprehensive cohort and randomized trial causal effect of PTCA vs. CABG on 5-year
mortality (%) for BARI
Comprehensive Cohort Causal Effect
Assumptions Parameter Estimate S.E. 95% C.I.
(A1), (A2) µ∗1 10.85% 0.72% 9.43% to 12.27%
µ∗0 9.16% 0.82% 7.55% to 10.77%
∆∗CC 1.68% 1.09% -0.46% to 3.83%
(A1), (A3) µ∗1 13.26% 1.15% 11.00% to 15.52%
µ∗0 10.00% 1.04% 7.96% to 12.03%
∆∗CC 3.27% 1.55% 0.22% to 6.31%
(A1), (A2), (A3) µ∗1 10.65% 0.70% 9.28% to 12.03%
µ∗0 9.57% 0.76% 8.08% to 11.06%
∆∗CC 1.08% 1.04% -0.95% to 3.11%
Randomized Trial Causal Effect
Assumptions Parameter Estimate S.E. 95% C.I.
(A1) ν∗1 13.31% 1.13% 11.08% to 15.53%
ν∗0 10.25% 1.02% 8.25% to 12.25%
∆∗RCT 3.06% 1.53% 0.06% to 6.05%
(A1), (A2), (A3) ν∗1 11.00% 0.77% 9.49% to 12.51%
ν∗0 9.92% 0.80% 8.36% to 11.49%
∆∗RCT 1.07% 1.11% -1.10% to 3.25%
5 Simulation studies
In the Appendix D, we present simulation studies, motivated by the BARI study, to evaluate the per-
formance of the five proposed estimators. We consider three simulation studies, corresponding to the
three sets of assumption represented in Figure 1. For each set of assumptions, we consider various
model misspecification scenarios. Since we have assumed that (A1) holds for all scenarios and ν˜
(A1)
t
is immune to model misspecification, all simulations demonstrate that it is unbiased, with excellence
correspondence between the average standard error and standard deviation of parameter estimates
and coverage of 95% confidence intervals close to their nominal level. The other estimators performed
consistent with theory.
6 Conclusion and Discussion
In this paper, we presented methods for estimating causal effects of a binary treatment in the CCS
design. We discussed three estimators of the comprehensive cohort causal effect and two estimators for
the randomized trial causal effect.
For the comprehensive cohort casual effect estimators, our data analysis and simulation study sug-
gest that the estimator that uses (A1) and (A2) is more efficient than the estimator that utilizes (A1)
and (A3). In fact, it is possible to manufacture data generating scenarios where the opposite is true.
The choice between the estimators should ultimately rely on substantive tenability of the underlying
assumptions.
For the randomized trial causal effect estimators, ν˜
(A1)
t has enviable robustness properties. If, how-
ever, (A2) and (A3) are tenable and either a model for τ∗t (X) or models for λ∗1(X) and π
∗
t (0,X) can be
correctly specified, sizable efficiency gains can be achieved by using ν˜
(A1,A2,A3)
t . In settings where it can
be difficult to enroll the requisite number of patients for an adequately powered randomized trial and
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one is interested in the randomized trials causal effect, the estimator may be a viable way of obtaining
more precise inferences. More detailed study of the bias-variance tradeoff associated with using data
from OBS to estimate the RCT effect is warranted.
Finally, for both estimands, the methods in this paper need to be extended to deal with non-
compliance, missing data, time-varying treatments and censored outcomes.
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Appendices
In what follows, we define π∗t (0,X,Y1,Y0) = P[T = t|R = 0,X,Y1,Y0]. It is also useful to note
that any observed data random variable can be written as: RTh1(X,Y1) + R(1 − T)h2(X,Y0) + (1 −
R)Th3(X,Y1) + (1− R)(1− T)h4(X,Y0) for some functions h1(X,Y1), h2(X,Y0), h3(X,Y1), h4(X,Y0).
A Orthogonal Complement of Tangent Spaces
A.1 Assumption (A1)
The observed data tangent space is:
T = A⊕ B
where
A = {E[a(R,X,Y1,Y0)|O] : E[a(R,X,Y1,Y0)] = 0}
B = {E[(1− R)(T − π∗1(0,X,Y1,Y0))b(X,Y1,Y0)|O] : b(X,Y1,Y0)}
The orthogonal complement of T is T ⊥ = A⊥ ∩ B⊥. Notice that
A⊥ = {RTh1(X,Y1) + R(1− T)h2(X,Y0) : π∗11h1(X,Y1) + π∗01h2(X,Y0) = 0} ⊕{
(1− R)Th3(X,Y1) + (1− R)(1− T)h4(X,Y0) :
π∗1(0,X,Y1,Y0)h3(X,Y1) + π
∗
0(0,X,Y1,Y0)h4(X,Y0) = 0
}
= {R(T − π∗11)h(X) : h(X)} ⊕{
(1− R)Th3(X,Y1) + (1− R)(1− T)h4(X,Y0) :
π∗1(0,X,Y1,Y0)h3(X,Y1) + π
∗
0(0,X,Y1,Y0)h4(X,Y0) = 0
}
We must now find elements of A⊥ that are in B⊥. We first note that R(T − π∗11)h(X) is in B⊥ for all
h(X). We now seek additional conditions on h3(X,Y1) and h4(X,Y1) such that (1− R)Th3(X,Y1) + (1−
R)(1− T)h4(X,Y0) is in B⊥. It must be the case that
0 = E[(T − π∗1(0,X,Y1,Y0){Th3(X,Y1) + (1− T)h4(X,Y0)}|R = 0,X,Y1,Y0]
= π∗1(0,X,Y1,Y0)π
∗
0(0,X,Y1,Y0){h3(X,Y1)− h4(X,Y0)}
This implies that h3(X,Y1) = h4(X,Y0). Imposing the condition on h3(X,Y1) and h4(X,Y1) from A
⊥,
we then have that h3(X,Y1) = h3(X,Y0) = 0. Thus, T
⊥ = {R(T − π∗11)h(X) : h(X)}.
A.2 Assumption (A1,A2)
The observed data tangent space is:
T = A′ ⊕ B′
where
A′ = {E[a(R,X,Y1,Y0)|O] : E[a(R,X,Y1,Y0)] = 0}
B′ = {(1− R)(T − π∗1(0,X))b(X) : b(X)}
Here, T ⊥ = A′⊥ ∩ B′⊥. Notice that
A
′⊥ = {RTh1(X,Y1) + R(1− T)h2(X,Y0) : π∗11h1(X,Y1) + π∗01h2(X,Y0) = 0} ⊕{
(1− R)Th3(X,Y1) + (1− R)(1− T)h4(X,Y0) :
π∗1(0,X)h3(X,Y1) + π
∗
0(0,X)h4(X,Y0) = 0
}
= {R(T − π∗11)h(X) : h(X)} ⊕ {(1− R)(T − π∗1(0,X))h(X) : h(X)}
We must now find elements of A
′⊥ that are in B′⊥. We first note that R(T − π∗11)h(X) is in B
′⊥ for
all h(X). We now seek additional conditions on b(X) such that (1− R)(T − π∗1(0,X))h(X) is in B⊥.
Since (1− R)(T − π∗1(0,X))h(X) ∈ B for all h(X), it must be the case that h(X) = 0. Thus, T ⊥ =
{R(T − π∗11)h(X) : h(X)}.
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A.3 Assumption (A1,A3)
The observed data tangent space is:
T = A† ⊕ B† ⊕ C†
where
A† = {E[a(X,Y1,Y0)|O] : E[a(X,Y1,Y0)] = 0}
B† = {E[(1− R)(T− π∗1(0,X,Y1,Y0))b(X,Y1,Y0)|O] : b(X,Y1,Y0)}
C† = {(R− λ∗1(X)}c(X) : c(X)}
Here, T ⊥ = A†⊥ ∩ B†⊥ ∩ C†⊥. Notice that
A†⊥ =
{
RTh1(X,Y1) + R(1− T)h2(X,Y0)+
(1− R)Th3(X,Y1) + (1− R)(1− T)h4(X,Y0) :
λ∗1(X)π
∗
11h1(X,Y1) + λ
∗
1(X)π
∗
01h2(X,Y0) +
λ∗0(X)π
∗
1(0,X,Y1,Y0)h3(X,Y1) + λ
∗
0(X)π
∗
0(0,X,Y1,Y0)h4(X,Y0) = 0
}
Let’s find elements of A†⊥ that are in B†⊥. The additional condition on h3(X,Y1) and h4(X,Y0) is
0 = E[(T − π∗1(0,X,Y1,Y0){Th3(X,Y1) + (1− T)h4(X,Y0)}|R = 0,X,Y1,Y0]
= π∗1(0,X,Y1,Y0)π
∗
0(0,X,Y1,Y0){h3(X,Y1)− h4(X,Y0)}
This implies that h3(X,Y1) = h4(X,Y0) = h(X) and
λ∗1(X)π
∗
11h1(X,Y1) + λ
∗
1(X)π
∗
01h2(X,Y0) + λ
∗
0(X)h(X) = 0
This can only hold if h1(X,Y1) = h1(X) and h2(X,Y0) = h2(X). Thus,
A†⊥ ∩ B†⊥ = {RTh1(X) + R(1− T)h2(X) + (1− R)h(X) :
λ∗1(X)π
∗
11h1(X) + λ
∗
1(X)π
∗
01h2(X) + λ
∗
0(X)h(X) = 0
}
We must now find elements of A†⊥ ∩ B†⊥ that are in C†⊥. The additional condition on h1(X), h2(X)
and h(X) is
0 = E[(R− λ∗1(X){RTh1(X) + R(1− T)h2(X) + (1− R)h(X)}|X]
= λ∗1(X)λ
∗
0(X)){π∗11h1(X) + π∗01h2(X)− h(X)}
This implies that π∗11h1(X) + π
∗
01h2(X) − h(X) = 0. Further imposing the condition from A†⊥ ∩ B†⊥,
we have h(X) = 0 and h2(X) = −π
∗
11
π∗01
a1(X). Thus, T
⊥ = {R(T − π∗11)a(X) : a(X)}.
A.4 Assumption (A1,A2,A3)
The observed data tangent space is:
T = A‡ ⊕ B‡ ⊕ C‡
where
A‡ = {E[a(X,Y1,Y0)|O] : E[a(X,Y1,Y0)] = 0}
B‡ = {(1− R)(T − π∗1(0,X))b(X) : b(X)}
C‡ = {(R− λ∗1(X)}c(X) : c(X)}
Here, T ⊥ = A‡⊥ ∩ B‡⊥ ∩ C‡⊥. Notice that
A‡⊥ =
{
RTh1(X,Y1) + R(1− T)h2(X,Y0)+
(1− R)Th3(X,Y1) + (1− R)(1− T)h4(X,Y0) :
λ∗1(X)π
∗
11h1(X,Y1) + λ
∗
1(X)π
∗
01h2(X,Y0) +
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λ∗0(X)π
∗
1(0,X)h3(X,Y1) + λ
∗
0(X)π
∗
0(0,X)h4(X,Y0) = 0
}
.
=

{
RT
λ∗1(X)π
∗
11
− (1− R)T
λ∗0(X)π
∗
1(0,X)
}
h1(X,Y1)+{
R(1− T)
λ∗1(X)π
∗
01
− (1− R)(1− T)
λ∗0(X)π
∗
0(0,X)
}
h2(X,Y0) +
(1− R)
λ∗0(X)
{
T − π∗1(0,X)
}
h(X) : h1(X,Y1), h2(X,Y0), h(X)
}
.
Let’s find elements of A‡⊥ that are in B‡⊥. The additional condition on h1(X,Y1), h2(X,Y0) and h(X) is
0 = E
(1− R)(T − π∗1(0,X))
{
− T
λ∗0(X)π
∗
1(0,X)
h1(X,Y1)− (1− T)
λ∗0(X)π
∗
0(0,X)
h2(X,Y0)+
{
T− π∗1(0,X)
λ∗0(X)
}
h(X)
 X

= h(X)π∗1 (0,X)π
∗
0(0,X)− π∗0(0,X)E[h1(X,Y1)|X] + π∗1(0,X)E[h2(X,Y1)|X]
which implies that
h(X) =
E[h1(X,Y1)|X]
π∗1(0,X)
− E[h2(X,Y1)|X]
π∗0(0,X)
Substituting this expression for h(X) into A‡⊥, we can now find elements in A†⊥ ∩ B†⊥ that are in C‡⊥.
The additional condition on h1(X,Y1) and h2(X,Y0) is
0 = E
(R− λ∗1(X))

{
RT
λ∗1(X)π
∗
11
− (1− R)T
λ∗0(X)π
∗
1(0,X)
}
h1(X,Y1)+
{
R(1− T)
λ∗1(X)π
∗
01
− (1− R)(1− T)
λ∗0(X)π
∗
0(0,X)
}
h2(X,Y0) +
{
1− R
λ∗0(X)
}{
T − π∗1(0,X)
λ∗0(X)
}{
E[h1(X,Y1)|X]
π∗1(0,X)
− E[h2(X,Y1)|X]
π∗0(0,X)
} X

= E[h1(X,Y1)|X] + E[h2(X,Y1)|X]
Let h˜1(X,Y1) = h1(X,Y1) − E[h1(X,Y1)|X] and h˜2(X,Y0) = h2(X,Y0)− E[h1(X,Y0)|X]. After algebra,
we can then write
T
⊥ =

{
RT
λ∗1(X)π
∗
11
− (1− R)T
λ∗0(X)π
∗
1(0,X)
}
h˜1(X,Y1) : E[h˜1(X,Y1)|X] = 0
⊕
{
R(1− T)
λ∗1(X)π
∗
01
− (1− R)(1− T)
λ∗0(X)π
∗
0(0,X)
}
h˜2(X,Y0) : E[h˜2(X,Y0)|X] = 0
⊕
{
R
λ∗1(X)
}{
T
π∗11
− 1− T
π∗01
}
h(X) : h(X)

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B Efficient Influence Functions and Estimators
For a given set of assumptions, the efficient influence for a target parameter is a naive influence function
minus its projection onto the orthogonal complement of the tangent space.
B.1 Assumption (A1)
Under (A1), µ∗t is not identified and so there are no influence functions to discuss. However, ν∗t is
identified and a naive influence function is
φν∗t (O) =
RI(T = t)
λ∗1π
∗
t1
(Yt − ν∗t )
The projection of φν∗t (O) onto T
⊥ is
R(T − π∗11)
E[(T − π∗11)φν∗t (O)|R = 1,X]
E[(T − π∗11)2|R = 1,X]
The projection reduces to
(−1)t+1R(T− π
∗
11)
λ∗1π
∗
t1
{
E[Yt|R = 1,X]− ν∗t
}
So, the efficient influence function for ν∗t is
R
λ∗1
 I(T = t)π∗t1 Yt +
{
1− I(T = t)
π∗t1
}
E[Yt|R = 1,X]− ν∗t

Let
ν˜
(−k)
t =
1
n− nk ∑Si 6=k
Riτ̂
(−k)
t (1,Xi)
λ̂
(−k)
1 (Xi)
be the plug-in estimator based on data excluding the kth split. The resulting estimator based on the kth
split is
ν˜
(−k)
t +
1
nk
∑
Si=k
Ri
λ̂
(−k)
1
 I(Ti = t)π∗t1 Yi +
{
1− I(Ti = t)
π∗t1
}
τ̂
(−k)
t (1,Xi)− ν˜(−k)t

B.2 Assumption (A1,A2)
Under (A1,A2), µ∗t is identified and a naive influence function is
φµ∗t (O) =
I(T = t)
π∗t (R,X)
(Yt − µ∗t ) + (−1)t(1− R)
T− π∗1(0,X)
π∗t (0,X)
{
E[Yt|R = 0,X]− µ∗t
}
The projection of φµ∗t (O) onto T
⊥ is
R(T − π∗11)
E[(T − π∗11)φµ∗t (O)|R = 1,X]
E[(T − π∗11)2|R = 1,X]
The projection reduces to
(−1)t+1R(T − π
∗
11)
π∗t1
{
E[Yt|R = 1,X]− µ∗t
}
So, the efficient influence function for µ∗t is
I(T = t)
π∗t (R,X)
Yt +
{
1− I(T = t)
π∗t (R,X)
}
E[Yt|R,X]− µ∗t
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The resulting estimator based on the kth split is
1
nk
∑
Si=k
 I(Ti = t)π̂(−k)t (Ri,Xi)Yi +
1− I(Ti = t)π̂(−k)t (Ri,Xi)
 τ̂(−k)t (Ri,Xi)
 ,
where π̂
(−k)
t (Ri,Xi) = Riπ
∗
t1 + (1− Ri)π̂(−k)t (0,Xi)
For ν∗t , the efficient influence curve under (A1,A2) is the same as under (A1), since T ⊥ is the same.
B.3 Assumption (A1,A3)
Under (A1,A3), µ∗t is identified and a naive influence function is
φµ∗t (O) =
RI(T = t)
λ∗1(X)π
∗
t1
{
Yt − µ∗t
}
+
{
1− R
λ∗1(X)
}{
E[Yt|R = 1,X]− µ∗t
}
The projection of φµ∗t (O) onto T
⊥ is
R(T − π∗11)
E[(T − π∗11)φµ∗t (O)|R = 1,X]
E[(T − π∗11)2|R = 1,X]
The projection reduces to
(−1)t+1R(T − π
∗
11)
π∗t1λ
∗
1(X)
{
E[Yt|R = 1,X]− µ∗t
}
So, the efficient influence function for µ∗t is
RI(T = t)
λ∗1(X)π
∗
t1
Yt +
{
1− RI(T = t)
λ∗1(X)π
∗
t1
}
E[Yt|R = 1,X]− µ∗t
The resulting estimator based on the kth split is
1
nk
∑
Si=k
 Ri I(Ti = t)λ̂(−k)1 (Xi)π∗t1Yi +
1− Ri I(Ti = t)λ̂(−k)1 (Xi)π∗t1
 τ̂(−k)t (1,Xi)

For ν∗t , the efficient influence curve under (A1,A3) is the same as under (A1), since T ⊥ is the same.
B.4 Assumption (A1,A2,A3)
The projection of any observed data random variable h(O) onto T ⊥ is
{
RT
λ∗1(X)π
∗
11
− (1− R)T
λ∗0(X)π
∗
1(0,X)
}
E
[{
RT
λ∗1(X)π
∗
11
− (1−R)T
λ∗0(X)π
∗
1 (0,X)
}
h(O) X,Y1
]
E
[{
RT
λ∗1(X)π
∗
11
− (1−R)T
λ∗0(X)π∗1 (0,X)
}2
X,Y1
] −
E

E
[{
RT
λ∗1(X)π
∗
11
− (1−R)T
λ∗0(X)π
∗
1 (0,X)
}
h(O) X,Y1
]
E
[{
RT
λ∗1(X)π
∗
11
− (1−R)T
λ∗0(X)π
∗
1 (0,X)
}2
X,Y1
] X

+
{
R(1− T)
λ∗1(X)π
∗
01
− (1− R)(1− T)
λ∗0(X)π∗0(0,X)
}
E
[{
R(1−T)
λ∗1(X)π
∗
01
− (1−R)(1−T)
λ∗0(X)π∗0 (0,X)
}
h(O) X,Y0
]
E
[{
R(1−T)
λ∗1(X)π
∗
01
− (1−R)(1−T)
λ∗0(X)π
∗
0 (0,X)
}2
X,Y0
] −
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E
E
[{
R(1−T)
λ∗1(X)π
∗
01
− (1−R)(1−T)
λ∗0(X)π
∗
0 (0,X)
}
h(O) X,Y0
]
E
[{
R(1−T)
λ∗1(X)π
∗
01
− (1−R)(1−T)
λ∗0(X)π
∗
0 (0,X)
}2
X,Y0
] X

+
{
R
λ∗1(X)
}{
T
π∗11
− 1− T
π∗01
} E [{ R
λ∗1(X)
}{
T
π∗11
− 1−Tπ∗01
}
h(O) X
]
E
[{
R
λ∗1(X)
}2 {
T
π∗11
− 1−Tπ∗01
}2
X
]
Under (A1,A2, A3), a naive influence function for µ∗t is
φµ∗t (O) =
RI(T = t)
λ∗1(X)π
∗
t1
{
Yt − µ∗t
}
+
{
1− R
λ∗1(X)
}{
E[Yt|X]− µ∗t
}
The projection of φµ∗t (O) onto T
⊥ is
I(T = t)
{
R
λ∗1(X)π
∗
t1
− 1
π∗t (X)
}{
Yt − E[Yt|X]
}
+
(−1)t+1
{
R
λ∗1(X)π
∗
t1
}
{T − π∗11}
{
E[Yt|X]− µ∗t
}
So, the efficient influence function for µ∗t is
I(T = t)
π∗t (X)
Yt +
{
1− I(T = t)
π∗t (X)
}
E[Yt|X]− µ∗t
The resulting estimator based on the kth split is
1
nk
∑
Si=k
 I(Ti = t)π(−k)t (Xi)Yi +
1− I(Ti = t)π(−k)t (Xi)
 τ̂(−k)t (Xi)
 ,
where π
(−k)
t (Xi) = λ̂
(−k)
1 (Xi)π
∗
t1 +
(
1− λ̂(−k)1 (Xi)
)
π̂
(−k)
t (0,Xi)
Under (A1,A2, A3), a naive influence function for ν∗t is
φν∗t (O) =
RI(T = t)
λ∗1π
∗
t1
(Yt − ν∗t )
The projection of φµ∗t (O) onto T
⊥ is
I(T = t)
{
Rπ∗t (X)
λ∗1(X)π
∗
t1
− 1
}{
λ∗1(X)
π∗t (X)λ∗1
}{
Yt − E[Yt|X]
}
+
(−1)t+1
{
R
λ∗1π
∗
t1
}
{T − π∗11}
{
E[Yt|X]− ν∗t
}
So, the efficient influence function for ν∗t is
I(T = t)λ∗1(X)
π∗t (X)λ∗1
Yt +
{
R− I(T = t)λ
∗
1(X)
π∗t (X)
}
E[Yt|X]
λ∗1
− R
λ∗1
ν∗t
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Let
νˇ
(−k)
t =
1
n− nk ∑Si 6=k
λ̂
(−k)
1 (Xi)τ̂
(−k)
t (Xi)
λ̂
(−k)
1
be the plug-in estimator based on data excluding the kth split. The resulting estimator based on the kth
split is
νˇ
(−k)
t +
1
nk
∑
Si=k
 I(Ti = t)λ̂
(−k)
1 (Xi)
π
(−k)
t (Xi)λ̂
(−k)
1
Yi +
Ri − I(Ti = t)λ̂
(−k)
1 (Xi)
π
(−k)
t (Xi)
 τ̂
(−k)
t (Xi)
λ̂
(−k)
1
− Ri
λ̂
(−k)
1
νˇ
(−k)
t

where π
(−k)
t (Xi) = λ̂
(−k)
1 (Xi)π
∗
t1 +
(
1− λ̂(−k)1 (Xi)
)
π̂
(−k)
t (0,Xi)
C Asymptotics
C.1 Theorem 1
It can be shown that
Rem(P, P∗) = E∗
(1− R)(π∗t (0,X)
πt(0,X)
− 1
) (
τ∗t (0,X)− τt(0,X)
)
Letting P be the estimator P̂(−k) and assuming π̂(−k)t (R,X) is bounded away from zero with probability
1, it follows that
|Rem(P̂(−k), P∗)| ≤ C(−k)
∥∥∥π̂(−k)t (0,X)− π∗t (0,X)∥∥∥
L2︸ ︷︷ ︸
OP∗(n−2/5k )
∥∥∥τ̂(−k)t (0,X)− τ∗t (0,X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n−2/5k )
(8)
where C(−k) is OP∗(1). This implies that that Regularity Condition 2 holds and
√
nkR2k is oP∗(1).
In terms of R1k is useful to notice that it is equal to
∫ {
φ(P̂(−k))(o)− φ(P∗)(o)
}
d(P
(k)
nk − P∗)(o),
where φ(P∗)(o) = G(A1,A2)µ∗t (P
∗)(o) + µ∗t . Thus,
√
nkR1k will be
OP∗
(∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
)
. Using the triangle and Cauchy-Schwarz inequalities, it can be shown that
∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
≤ D(−k)1
∥∥∥π̂(−k)t (0,X)− π∗t (0,X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
+ (9)
D
(−k)
2
∥∥∥τ̂(−k)t (0,X)− τ∗t (0,X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
+
D
(−k)
3
∥∥∥τ̂(−k)t (1,X)− τ∗(1,X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
. (10)
where D
(−k)
1 , D
(−k)
2 and D
(−k)
3 are OP∗(1). Thus,
∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
is oP∗(1) (i.e., Regularity Condi-
tion 1 holds) and
√
nkR1k is oP∗(1).
C.2 Theorem 2
It can be shown that
Rem(P, P∗) = E∗
(λ∗1(X)
λ1(X)
− 1
) (
τ∗t (1,X)− τt(1,X)
)
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Letting P be the estimator P̂(−k) and assuming λ̂(−k)1 (X) is bounded away from zero with probability 1,
it follows that
|Rem(P̂(−k), P∗)| ≤ C(−k)1
∥∥∥λ̂(−k)1 (X)− λ∗1(X)∥∥∥L2︸ ︷︷ ︸
OP∗ (n
−2/5
k )
∥∥∥τ̂(−k)t (1,X)− τ∗t (1,X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n
−2/5
k )
where C
(−k)
1 is OP∗(1). This implies that that Regularity Condition 2 holds and
√
nkR2k is oP∗(1)
In terms of R1k, we note that it is equal to
∫ {
φ(P̂(−k))(o)− φ(P∗)(o)
}
d(P
(k)
nk − P∗)(o), where
φ(P∗)(o) = G(A1,A3)µ∗t (P
∗)(o) + µ∗t . Thus,
√
nkR1k will be
OP∗
(∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
)
. Using the triangle and Cauchy-Schwarz inequalities, it can be shown that
∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
≤ D(−k)1
∥∥∥λ̂(−k)1 (X)− λ∗1(X)∥∥∥L2︸ ︷︷ ︸
o∗P(1)
+D
(−k)
2
∥∥∥τ̂(−k)t (1,X)− τ∗t (1,X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
for D
(−k)
1 and D
(−k)
2 are OP∗(1). Thus,
∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
is oP∗(1) (i.e., Regularity Condition 1 holds)
and
√
nkR1k is oP∗(1)
C.3 Theorem 3
It can be shown that
Rem(P, P∗) = E∗
(π∗t (X)
πt(X)
− 1
) (
τ∗t (X)− τt(X)
)
Letting P be the estimator P̂(−k) and assuming π̂(−k)t (X) is bounded away from zero with probability 1,
it follows that
|Rem(P̂(−k), P∗)| ≤ C(−k)1
∥∥∥π̂(−k)t (X)− π∗t (X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n
−2/5
k )
∥∥∥τ̂(−k)t (X)− τ∗t (X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n
−2/5
k )
where C
(−k)
1 is OP∗(1). This implies that that Regularity Condition 2 holds and
√
nkR2k is oP∗(1)
In terms of R1k, we note that it is equal to
∫ {
φ(P̂(−k))(o)− φ(P∗)(o)
}
d(P
(k)
nk − P∗)(o), where
φ(P∗)(o) = G(A1,A2,A3)µ∗t (P
∗)(o) + µ∗t . Thus,
√
nkR1k will be
OP∗
(∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
)
. Using the triangle and Cauchy-Schwarz inequalities, it can be shown that
∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
≤ D(−k)1
∥∥∥π̂(−k)t (X)− π∗t (X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
+D
(−k)
2
∥∥∥τ̂(−k)t (X)− τ∗t (X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
for D
(−k)
1 and D
(−k)
2 are OP∗(1). Thus,
∥∥∥φ(P̂(−k))− φ(P∗)∥∥∥
L2
is oP∗(1) (i.e., Regularity Condition 1 holds)
and
√
nkR1k is oP∗(1)
C.4 Theorem 4
It can be shown that
Rem(P, P∗) =
(
1− λ
∗
1
λ1
)
(νt − ν∗t )
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Letting P be the estimator P̂(−k), it follows that
|Rem(P̂(−k), P∗)| ≤ C(−k)1 | λ̂(−k)1 − λ∗1 |︸ ︷︷ ︸
OP∗ (1/
√
n)
|ν̂(−k)t − ν∗t |︸ ︷︷ ︸
oP∗ (1)
where C
(−k)
1 is OP∗(1). This implies that that Regularity Condition 2 holds and
√
nkR2k is oP∗(1)
Using the triangle and Cauchy-Schwarz inequalities, it can be shown that∥∥∥G(P̂(−k))− G(P∗)∥∥∥
L2
≤ D(−k)1 | λ̂(−k)1 − λ∗1 |︸ ︷︷ ︸
o∗P(1)
+D
(−k)
2
∥∥∥τ̂(−k)t (1,X)− τ∗t (1,X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
+
D
(−k)
3 | ν̂(−k)t − ν∗t |︸ ︷︷ ︸
o∗P(1)
for D
(−k)
1 , D
(−k)
2 , and D
(−k)
3 are OP∗(1). Thus, Regularity Condition 1 holds and
√
nkR1k is oP∗(1)
C.5 Theorem 5
It can be shown that
Rem(P, P∗) =
1
λ1
E∗
[
λ1(X)
πt(X)
(
π∗t (X)− πt(X)
) (
τt(X)− τ∗t (X)
)]
+
1
λ1
E∗
[(
λ1(X)− λ∗1(X)
) (
τt(X)− τ∗t (X)
)]
+
(
1− λ
∗
1
λ1
)
(νt − ν∗t )
Letting P be the estimator P̂(−k), it follows that
|Rem(P̂(−k), P∗)| ≤ C(−k)1
∥∥∥π̂(−k)t (X)− π∗t (X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n−2/5k )
∥∥∥τ̂(−k)t (X)− τ∗t (X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n−2/5k )
+
C
(−k)
2
∥∥∥λ̂(−k)1 (X)− λ∗1(X)∥∥∥L2︸ ︷︷ ︸
OP∗ (n−2/5k )
∥∥∥τ̂(−k)t (X)− τ∗t (X)∥∥∥
L2︸ ︷︷ ︸
OP∗ (n−2/5k )
+
C
(−k)
3 | λ̂(−k)1 − λ∗1 |︸ ︷︷ ︸
OP∗ (n
−1/2
k )
|ν̂(−k)t − ν∗t |︸ ︷︷ ︸
oP∗ (1)
where C
(−k)
1 , C
(−k)
2 and C
(−k)
3 are OP∗(1). This implies that that Regularity Condition 2 holds and√
nkR2k is oP∗(1)
Using the triangle and Cauchy-Schwarz inequalities, it can be shown that∥∥∥G(P̂(−k))− G(P∗)∥∥∥
L2
≤ D(−k)1
∥∥∥π̂(−k)t (X)− π∗t (X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
+D
(−k)
2
∥∥∥λ̂(−k)1 (X)− λ∗1(X)∥∥∥L2︸ ︷︷ ︸
o∗P(1)
+
D
(−k)
3
∥∥∥τ̂(−k)t (X)− τ∗t (X)∥∥∥
L2︸ ︷︷ ︸
o∗P(1)
+D
(−k)
4 | λ̂(−k)1 − λ∗1 |︸ ︷︷ ︸
o∗P(1)
+
D
(−k)
5 | ν̂(−k)t − ν∗t |︸ ︷︷ ︸
o∗P(1)
for D
(−k)
1 , D
(−k)
2 , D
(−k)
3 , D
(−k)
4 and D
(−k)
5 that are OP∗(1). Thus, Regularity Condition 1 holds and√
nkR1k is oP∗(1)
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D Simulation studies
We present simulation studies, motivated by the BARI study, to evaluate the performance of the five
proposed estimators. We consider three simulation studies, corresponding to the three sets of assump-
tion represented in Figure 1 of the manuscript. For each set of assumptions, we consider various model
misspecification scenarios. We simulated 5000 datasets, each with a sample size of n = 2000. Datasets
were analyzed with K = 5 sample splits. We report average bias, average of standard error estimate,
Monte Carlo standard deviation of the estimator, coverage of 95%Wald confidence intervals and Monte
Carlo mean squared error for the three estimators of µ∗1 and µ
∗
0 and for the two estimators of ν
∗
1 and ν
∗
0 .
Since we have assumed that (A1) holds for all scenarios and ν˜
(A1)
t is immune to model misspecification,
all simulations demonstrate that it is unbiased, with excellence correspondence between the average
standard error and standard deviation of parameter estimates and coverage of 95% confidence intervals
close to their nominal level.
D.1 Study 1: Assumptions (A1) and (A2)
In this simulation study, we let λ∗1(X), π
∗
1(0,X) , τ
∗
1 (0,X) and τ
∗
0 (0,X), be equal to the estimated
functions obtained from fitting the generalized additive logistic models to the BARI data. We generated
data according to the following procedure:
1. Draw X from the empirical distribution of the 12 covariates utilized in our analysis of the BARI
study;
2. Draw U ∼ Normal(0, 1) independent of X;
3. Draw R ∼ Bernoulli(Φ(∆R(X) +U); 0, 1) where ∆R(X) = Φ−1(λ∗1(X), 0, 2) and Φ(·, a, b) is the cu-
mulative distribution function of a normal random variable with mean a and variance b;
4. If R = 1, draw T ∼ Bernoulli(0.5); If R = 0, draw T ∼ Bernoulli(π∗1(0,X))
5. Let ∆Yt(X) be the solution to
Φ2(∆Yt(X),∆R(X); 0,Σ) = τ
∗
1 (X){1− λ∗1(X)}
where Φ2(·, ·; a,B) is the cumulative distribution function of a bivariate normal random vector mean
a and variance-covariance matrix B and Σ is a variance-covariance matrix with variance 1 and co-
variance 2. For t = 0, 1, draw Yt ∼ Bernoulli(Φ(∆Yt(X) +U; 0, 1))
6. Set Y = TY1 + (1− T)Y0
Steps 3 and 5 use the idea of generating correlated binary outcomes discussed by Swihart et al. [2014];
the conditional distribution of R given X is Bernoulli(λ∗1(X)) and the conditional distribution of Yt
given R = 0 and X is Bernoulli(τ∗t (0,X)).
Table 4 presents the results of the simulation study. In addition to evaluating the five estimators
under correct model specification - (a), we considered the following three misspecification scenarios:
(b) π̂1(0,X) is replaced by Φ(logit{π̂1(0,X)}; 0, 25);
(c) τ̂t(0,X) is replaced by Φ(logit{τ̂t(0,X)}; 0, 25);
(d) π̂1(0,X) and τ̂t(0,X) are replaced by Φ(logit{π̂1(0,X)}; 0, 25) and
Φ(logit{τ̂t(0,X)}; 0, 25), respectively.
Table 4 shows that, when either the model for π∗t (0,X) or τ∗t (X) is modeled correctly, then µ˜
(A1,A2)
t
performs well, but it performs poorly when both models are misspecified. As expected, the estimators
µ˜
(A1,A3)
t , µ˜
(A1,A2,A3)
t and ν˜
(A1,A2,A3)
t perform poorly for all scenarios.
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Table 4: Simulation results: (A1), (A2)
(a) π∗t (0,X) and τ∗t (0,X) modeled correctly.
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 0.03% 1.23% 1.23% 94.72% 1.23%
µ˜
(A1,A3)
1 10.09% 2.09% 2.09% 0.10% 10.30%
µ˜
(A1,A2,A3)
1 -1.13% 1.18% 1.17% 83.04% 1.63%
µ∗0 µ˜
(A1,A2)
0 -0.01% 1.36% 1.34% 95.30% 1.34%
µ˜
(A1,A3)
0 8.78% 1.96% 1.94% 0.40% 8.99%
µ˜
(A1,A2,A3)
0 1.58% 1.36% 1.36% 79.86% 2.08%
ν∗1 ν˜
(A1)
1 0.04% 2.03% 2.05% 94.82% 2.05%
ν˜
(A1,A2,A3)
1 -11.18% 1.32% 1.31% 0.00% 11.25%
ν∗0 ν˜
(A1)
0 0.01% 1.94% 1.95% 95.06% 1.95%
ν˜
(A1,A2,A3)
0 -7.24% 1.49% 1.50% 0.32% 7.39%
(b) π∗t (0,X) modeled incorrectly, τ∗t (0,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 0.00% 1.23% 1.18% 95.60% 1.18%
µ˜
(A1,A3)
1 9.66% 2.09% 2.07% 0.16% 9.88%
µ˜
(A1,A2,A3)
1 -1.07% 1.22% 1.14% 86.80% 1.56%
µ∗0 µ˜
(A1,A2)
0 0.06% 1.16% 1.26% 93.00% 1.26%
µ˜
(A1,A3)
0 8.35% 1.95% 1.97% 0.78% 8.58%
µ˜
(A1,A2,A3)
0 1.53% 1.19% 1.33% 72.64% 2.03%
ν∗1 ν˜
(A1)
1 -0.01% 2.02% 2.03% 94.38% 2.03%
ν˜
(A1,A2,A3)
1 -10.56% 1.36% 1.28% 0.00% 10.64%
ν∗0 ν˜
(A1)
0 0.00% 1.92% 1.96% 94.88% 1.96%
ν˜
(A1,A2,A3)
0 -6.70% 1.36% 1.47% 0.40% 6.86%
(c) π∗t (0,X) modeled correctly, τ∗t (0,X) modeled incorrectly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -0.18% 1.23% 1.18% 95.38% 1.19%
µ˜
(A1,A3)
1 9.93% 2.09% 2.02% 0.04% 10.13%
µ˜
(A1,A2,A3)
1 -1.11% 1.16% 1.12% 83.60% 1.58%
µ∗0 µ˜
(A1,A2)
0 -0.51% 1.42% 1.35% 94.36% 1.44%
µ˜
(A1,A3)
0 8.65% 1.94% 1.95% 0.32% 8.87%
µ˜
(A1,A2,A3)
0 1.48% 1.33% 1.35% 81.08% 2.00%
ν∗1 ν˜
(A1)
1 0.02% 2.02% 1.98% 95.30% 1.98%
ν˜
(A1,A2,A3)
1 -10.93% 1.28% 1.25% 0.00% 11.00%
ν∗0 ν˜
(A1)
0 -0.03% 1.92% 1.95% 94.14% 1.95%
ν˜
(A1,A2,A3)
0 -7.16% 1.46% 1.47% 0.32% 7.31%
(d) π∗t (0,X) and τ∗t (0,X) modeled incorrectly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -1.68% 1.28% 1.21% 74.32% 2.07%
µ˜
(A1,A3)
1 9.75% 2.08% 2.03% 0.14% 9.96%
µ˜
(A1,A2,A3)
1 -1.18% 1.23% 1.15% 84.50% 1.65%
µ∗0 µ˜
(A1,A2)
0 1.79% 1.19% 1.36% 66.26% 2.25%
µ˜
(A1,A3)
0 8.46% 1.94% 1.91% 0.32% 8.67%
µ˜
(A1,A2,A3)
0 1.61% 1.20% 1.33% 72.62% 2.09%
ν∗1 ν˜
(A1)
1 -0.05% 2.02% 2.00% 95.24% 2.01%
ν˜
(A1,A2,A3)
1 -10.97% 1.37% 1.29% 0.00% 11.05%
ν∗0 ν˜
(A1)
0 0.03% 1.93% 1.94% 94.66% 1.94%
ν˜
(A1,A2,A3)
0 -6.84% 1.37% 1.48% 0.46% 7.00%
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D.2 Study 2: Assumptions (A1) and (A3)
In this simulation study, we let λ∗1(X), π
∗
1(0,X), τ
∗
1 (1,X) and τ
∗
0 (1,X), be equal to the estimated func-
tions obtained from fitting the generalized additive logistic models to the BARI data. We generated
data according to the following procedure:
1. Draw X from the empirical distribution of the 12 covariates utilized in our analysis of the BARI
study;
2. Draw U ∼ Normal(0, 1) independent of X;
3. Draw R ∼ Bernoulli(λ∗1(X))
4. If R = 1, draw T ∼ Bernoulli(0.5); If R = 0, draw T ∼ Bernoulli(expit{logit{π∗1(0,X))− 2U}})
5. Draw Yt ∼ Bernoulli(Φ(∆Yt (X) +U); 0, 1), where ∆Yt(X) = Φ−1(τ∗t (1,X), 0, 2).
6. Set Y = TY1 + (1− T)Y0
Step 5 ensures that the conditional distribution of Yt given X is Bernoulli(τ∗t (1,X)).
Table 5 presents the results of the simulation study. In addition to evaluating the five estimators
under correct model specification - (a), we considered the following three misspecification scenarios:
(b) λ̂1(X) is replaced by 0.7Φ(logit{λ̂1(X)}; 0, 25) + 0.3Φ(logit{λ̂1(X)}; 0.8, 0.04);
(c) τ̂t(1,X) is replaced by Φ(logit{τ̂t(1,X)}; 0, 25);
(d) λ̂1(X) and τ̂t(1,X) are replaced by 0.7Φ(logit{λ̂1(X)}; 0, 25) +
0.3Φ(logit{λ̂1(X)}; 0.8, 0.04) and Φ(logit{τ̂t(1,X)}; 0, 25), respectively.
Table 5 shows that, when either the model for λ∗1(X) or τ
∗
t (1,X) is modeled correctly, then µ˜
(A1,A3)
t
performs well, but it performs poorly when both models are misspecified. As expected, the estimators
µ˜
(A1,A2)
t , µ˜
(A1,A2,A3)
t and ν˜
(A1,A2,A3)
t perform poorly for all scenarios.
D.3 Study 3: Assumptions (A1), (A2) and (A3)
In this simulation study, we let λ∗1(X), π
∗
1(0,X), τ
∗
1 (X) and τ
∗
0 (X), be equal to the estimated functions
obtained from fitting the generalized additive logistic models to the BARI data. We generated data
according to the following procedure:
1. Draw X from the empirical distribution of the 12 covariates utilized in our analysis of the BARI
study;
2. Draw U ∼ Normal(0, 1) independent of X;
3. Draw R ∼ Bernoulli(λ∗1(X))
4. If R = 1, draw T ∼ Bernoulli(0.5); If R = 0, draw T ∼ Bernoulli(π∗1(0,X)))
5. Draw Yt ∼ Bernoulli(Φ(∆Yt (X) +U); 0, 1), where ∆Yt(X) = Φ−1(τ∗t (X), 0, 2).
6. Set Y = TY1 + (1− T)Y0
Step 5 ensures that the conditional distribution of Yt given X is Bernoulli(τ∗t (X)).
Table 6 presents the results of the simulation study. In addition to evaluating the five estimators
under correct model specification - (a), we considered the following seven misspecification scenarios:
(b) λ̂1(X) is replaced by 0.7Φ(logit{λ̂1(X)}; 0, 25) + 0.3Φ(logit{λ̂1(X)}; 0.8, 0.04);
(c) π̂1(0,X) is replaced by Φ(logit{π̂1(0,X)}; 0, 25);
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Table 5: Simulation results: (A1), (A3)
(a) λ∗1(X), τ
∗
t (1,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -3.25% 0.91% 0.90% 6.72% 3.37%
µ˜
(A1,A3)
1 -0.02% 1.53% 1.51% 94.84% 1.51%
µ˜
(A1,A2,A3)
1 -3.50% 0.88% 0.86% 2.98% 3.60%
µ∗0 µ˜
(A1,A2)
0 4.25% 1.29% 1.27% 6.90% 4.43%
µ˜
(A1,A3)
0 -0.01% 1.36% 1.34% 95.02% 1.34%
µ˜
(A1,A2,A3)
0 3.64% 1.14% 1.14% 9.04% 3.82%
ν∗1 ν˜
(A1)
1 -0.02% 1.47% 1.47% 94.88% 1.47%
ν˜
(A1,A2,A3)
1 -3.43% 0.97% 0.94% 7.02% 3.55%
ν∗0 ν˜
(A1)
0 -0.01% 1.32% 1.33% 94.62% 1.33%
ν˜
(A1,A2,A3)
0 3.58% 1.18% 1.19% 12.24% 3.77%
(b) λ∗1(X) modeled incorrectly, τ
∗
t (1,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -3.30% 0.91% 0.91% 6.12% 3.43%
µ˜
(A1,A3)
1 -0.05% 2.00% 1.52% 98.88% 1.52%
µ˜
(A1,A2,A3)
1 -3.52% 0.87% 0.88% 2.94% 3.62%
µ∗0 µ˜
(A1,A2)
0 4.08% 1.28% 1.23% 7.66% 4.27%
µ˜
(A1,A3)
0 -0.04% 1.80% 1.37% 98.66% 1.37%
µ˜
(A1,A2,A3)
0 3.54% 1.18% 1.12% 11.74% 3.71%
ν∗1 ν˜
(A1)
1 -0.01% 1.47% 1.48% 94.64% 1.48%
ν˜
(A1,A2,A3)
1 -3.39% 0.74% 0.96% 3.44% 3.52%
ν∗0 ν˜
(A1)
0 -0.01% 1.31% 1.33% 94.60% 1.33%
ν˜
(A1,A2,A3)
0 3.46% 0.92% 1.15% 6.08% 3.65%
(c) λ∗1(X) modeled correctly, τ
∗
t (1,X) modeled incorrectly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -3.33% 0.96% 0.96% 7.28% 3.47%
µ˜
(A1,A3)
1 -0.24% 1.71% 1.64% 95.16% 1.66%
µ˜
(A1,A2,A3)
1 -3.55% 0.88% 0.89% 3.22% 3.66%
µ∗0 µ˜
(A1,A2)
0 4.25% 1.34% 1.31% 9.10% 4.44%
µ˜
(A1,A3)
0 -0.22% 1.58% 1.50% 95.10% 1.52%
µ˜
(A1,A2,A3)
0 3.67% 1.14% 1.14% 8.38% 3.84%
ν∗1 ν˜
(A1)
1 0.00% 1.58% 1.59% 94.28% 1.59%
ν˜
(A1,A2,A3)
1 -3.43% 0.97% 0.97% 7.60% 3.56%
ν∗0 ν˜
(A1)
0 0.03% 1.46% 1.47% 94.42% 1.47%
ν˜
(A1,A2,A3)
0 3.57% 1.17% 1.17% 11.88% 3.76%
(d) λ∗1(X), τ
∗
t (1,X) modeled incorrectly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -3.22% 0.96% 0.94% 8.68% 3.36%
µ˜
(A1,A3)
1 -6.76% 2.24% 1.85% 10.92% 7.01%
µ˜
(A1,A2,A3)
1 -3.44% 0.88% 0.87% 3.20% 3.55%
µ∗0 µ˜
(A1,A2)
0 4.08% 1.32% 1.27% 10.02% 4.27%
µ˜
(A1,A3)
0 -7.23% 2.08% 1.67% 3.90% 7.42%
µ˜
(A1,A2,A3)
0 3.54% 1.18% 1.12% 11.26% 3.71%
ν∗1 ν˜
(A1)
1 -0.00% 1.58% 1.59% 94.62% 1.59%
ν˜
(A1,A2,A3)
1 -3.38% 0.75% 0.96% 3.60% 3.51%
ν∗0 ν˜
(A1)
0 -0.04% 1.46% 1.47% 94.36% 1.47%
ν˜
(A1,A2,A3)
0 3.47% 0.93% 1.16% 5.86% 3.66%
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(d) τ̂t(X), τ̂t(1,X) and τ̂t(0,X) are replaced by Φ(logit{τ̂t(X)}; 0, 25), Φ(logit{τ̂t(1,X)}; 0, 25) and
Φ(logit{τ̂t(0,X)}; 0, 25), respectively;
(e) λ̂1(X) and π̂1(0,X) are replaced by 0.7Φ(logit{λ̂1(X)}; 0, 25) + 0.3Φ(logit{λ̂1(X)}; 0.8, 0.04)
and Φ(logit{π̂1(1,X)}; 0, 25), respectively;
(f) λ̂1(X), τ̂t(X), τ̂t(1,X) and τ̂t(0,X) are replaced by 0.7Φ(logit{λ̂1(X)}; 0, 25) +
0.3Φ(logit{λ̂1(X)}; 0.8, 0.04), Φ(logit{τ̂t(X)}; 0, 25), Φ(logit{τ̂t(1,X)}; 0, 25) and
Φ(logit{τ̂t(0,X)}; 0, 25), respectively;
(g) π̂1(0,X), τ̂t(X), τ̂t(1,X) and τ̂t(0,X) are replaced are replaced by Φ(logit{π̂1(0,X)}; 0, 25),
Φ(logit{τ̂t(X)}; 0, 25), Φ(logit{τ̂t(1,X)}; 0, 25) and Φ(logit{τ̂t(0,X)}; 0, 25), respectively;
(h) λ̂1(X), π̂1(0,X), τ̂t(X), τ̂t(1,X) and τ̂t(0,X) are replaced by
0.7Φ(logit{λ̂1(X)}; 0, 25) + 0.3Φ(logit{λ̂1(X)}; 0.8, 0.04),
Φ(logit{π̂1(0,X)}; 0, 25), Φ(logit{τ̂t(X)}; 0, 25),
Φ(logit{τ̂t(1,X)}; 0, 25) and Φ(logit{τ̂t(0,X)}; 0, 25), respectively.
Table 6 shows that, when either the model for λ∗1(X) or τ
∗
t (1,X) is modeled correctly, then µ˜
(A1,A3)
t
performs well, but it performs poorly when both models are misspecified. As expected, the estimators
µ˜
(A1,A2)
t , µ˜
(A1,A2,A3)
t and ν˜
(A1,A2,A3)
t perform poorly for all scenarios.
Under simulation scenarios (a)-(e), we see that all estimators are unbiased. Among the CC estima-
tors, µ˜
(A1,A2,A3)
t is slightly more efficient than µ˜
(A1,A3)
t and both are much more efficient than µ˜
(A1,A3)
t .
Between the two RCT estimators, ν˜
(A1,A2,A3)
t is substantially more efficient than ν˜
(A1)
t . As expected
under model misspecification, we do see (1) some poor correspondence between the average standard
error and the standard deviation of parameter estimates and (2) coverage of estimated 95% confidence
intervals different than their nominal level. For Scenario (b), this can seen for µ˜
(A1,A3)
t , µ˜
(A1,A2,A3)
t , and
ν˜
(A1,A2,A3)
t . For Scenario (c), it can also be seen for µ˜
(A1,A3)
0 , µ˜
(A1,A2,A3)
0 , and ν˜
(A1,A2,A3)
0 .
Under simulation scenarios (f)-(h), the estimators that rely on Assumptions (A1), (A2) and (A3)
perform poorly. Under scenarios (f) and (h), estimators that rely on Assumptions (A1) and (A3) perform
poorly, whereas for scenarios (g) and (h), estimators that rely Assumptions (A1) and (A2) that perform
poorly.
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Table 6: Simulation results: (A1), (A2), (A3)
(a) λ∗1(X), π
∗
t (0,X), τ
∗
t (X) = τ
∗
t (1,X) = τ
∗
t (0,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 0.01% 0.97% 0.94% 95.32% 0.94%
µ˜
(A1,A3)
1 -0.02% 1.42% 1.39% 95.08% 1.39%
µ˜
(A1,A2,A3)
1 0.01% 0.94% 0.91% 95.24% 0.91%
µ∗0 µ˜
(A1,A2)
0 -0.05% 1.20% 1.19% 95.02% 1.19%
µ˜
(A1,A3)
0 -0.01% 1.36% 1.34% 94.82% 1.34%
µ˜
(A1,A2,A3)
0 -0.01% 1.02% 1.02% 94.82% 1.02%
ν∗1 ν˜
(A1)
1 0.00% 1.40% 1.38% 95.22% 1.38%
ν˜
(A1,A2,A3)
1 0.02% 1.03% 1.00% 95.40% 1.00%
ν∗0 ν˜
(A1)
0 0.00% 1.34% 1.35% 94.68% 1.35%
ν˜
(A1,A2,A3)
0 -0.00% 1.09% 1.10% 95.40% 1.00%
(b) λ∗1(X) modeled incorrectly, π
∗
t (0,X), τ
∗
t (X) = τ
∗
t (1,X) = τ
∗
t (0,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -0.01% 0.96% 0.98% 94.50% 0.98%
µ˜
(A1,A3)
1 -0.04% 1.90% 1.44% 98.50% 1.44%
µ˜
(A1,A2,A3)
1 -0.00% 0.92% 0.95% 93.94% 0.95%
µ∗0 µ˜
(A1,A2)
0 -0.04% 1.20% 1.19% 95.64% 1.19%
µ˜
(A1,A3)
0 -0.03% 1.80% 1.35% 98.84% 1.35%
µ˜
(A1,A2,A3)
0 -0.00% 1.09% 1.02% 95.80% 1.02%
ν∗1 ν˜
(A1)
1 -0.02% 1.40% 1.43% 94.50% 1.43%
ν˜
(A1,A2,A3)
1 -0.01% 0.77% 1.03% 85.48% 1.03%
ν∗0 ν˜
(A1)
0 -0.01% 1.33% 1.34% 94.20% 1.34%
ν˜
(A1,A2,A3)
0 -0.01% 0.88% 1.08% 88.92% 1.08%
(c) π∗t (0,X) modeled incorrectly, λ∗1(X), τ
∗
t (X) = τ
∗
t (1,X) = τ
∗
t (0,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -0.02% 0.98% 0.95% 95.68% 0.95%
µ˜
(A1,A3)
1 0.00% 1.42% 1.42% 94.58% 1.42%
µ˜
(A1,A2,A3)
1 -0.02% 0.98% 0.93% 96.18% 0.93%
µ∗0 µ˜
(A1,A2)
0 0.02% 0.91% 1.08% 89.76% 1.08%
µ˜
(A1,A3)
0 -0.05% 1.35% 1.35% 94.64% 1.35%
µ˜
(A1,A2,A3)
0 -0.02% 0.90% 1.01% 91.26% 1.01%
ν∗1 ν˜
(A1)
1 0.01% 1.39% 1.41% 94.44% 1.41%
ν˜
(A1,A2,A3)
1 -0.03% 1.05% 1.01% 96.00% 1.01%
ν∗0 ν˜
(A1)
0 -0.04% 1.32% 1.34% 94.38% 1.34%
ν˜
(A1,A2,A3)
0 -0.02% 0.98% 1.08% 91.74% 1.08%
(d) τ∗t (X) = τ∗t (1,X) = τ∗t (0,X) modeled incorrectly, λ∗1(X) and π
∗
t (0,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -0.20% 1.02% 1.00% 95.04% 1.02%
µ˜
(A1,A3)
1 -0.28% 1.60% 1.53% 94.74% 1.55%
µ˜
(A1,A2,A3)
1 -0.13% 1.00% 0.97% 95.54% 0.97%
µ∗0 µ˜
(A1,A2)
0 -0.55% 1.31% 1.21% 93.70% 1.32%
µ˜
(A1,A3)
0 -0.27% 1.54% 1.48% 95.26% 1.50%
µ˜
(A1,A2,A3)
0 -0.21% 1.15% 1.10% 95.40% 1.12%
ν∗1 ν˜
(A1)
1 -0.04% 1.49% 1.51% 93.90% 1.51%
ν˜
(A1,A2,A3)
1 -0.16% 1.18% 1.04% 96.92% 1.05%
ν∗0 ν˜
(A1)
0 -0.03% 1.44% 1.47% 94.48% 1.47%
ν˜
(A1,A2,A3)
0 -0.14% 1.24% 1.16% 96.28% 1.16%
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Table 6: Simulation results: (A1), (A2), (A3) (continued)
(e) λ∗1(X), π
∗
t (0,X) modeled incorrectly, τ
∗
t (X) = τ
∗
t (1,X) = τ
∗
t (0,X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 0.02% 0.97% 0.93% 95.50% 0.93%
µ˜
(A1,A3)
1 0.04% 1.86% 1.41% 99.06% 1.41%
µ˜
(A1,A2,A3)
1 0.02 0.95% 0.90% 95.66% 0.91%
µ∗0 µ˜
(A1,A2)
0 0.03% 0.90% 1.06% 90.60% 1.06%
µ˜
(A1,A3)
0 0.02% 1.77% 1.36% 98.54% 1.36%
µ˜
(A1,A2,A3)
0 0.02% 0.90% 1.00% 92.24% 1.00%
ν∗1 ν˜
(A1)
1 0.03% 1.37% 1.39% 94.30% 1.39%
ν˜
(A1,A2,A3)
1 0.01% 0.78% 0.98% 88.16% 0.98%
ν∗0 ν˜
(A1)
0 0.02% 1.31% 1.35% 93.90% 1.35%
ν˜
(A1,A2,A3)
0 -0.00% 0.75% 1.07% 82.84% 1.07%
(f) λ∗1(X), τ
∗
t (X) = τ
∗
t (1,X) = τ
∗
t (0,X) modeled incorrectly, π
∗
t (0,X) modeled correctly,
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -0.17% 1.03% 1.00% 95.02% 1.01%
µ˜
(A1,A3)
1 -7.17% 2.14% 1.67% 5.40% 7.37%
µ˜
(A1,A2,A3)
1 0.46% 1.00% 0.98% 93.44% 1.83%
µ∗0 µ˜
(A1,A2)
0 -0.53% 1.32% 1.21% 94.40% 1.32%
µ˜
(A1,A3)
0 -7.11% 2.06% 1.63% 3.98% 7.29%
µ˜
(A1,A2,A3)
0 -1.45% 1.24% 1.12% 79.92% 1.83%
ν∗1 ν˜
(A1)
1 -0.01% 1.50% 1.48% 95.32% 1.48%
ν˜
(A1,A2,A3)
1 5.78% 0.86% 1.02% 0.00% 5.86%
ν∗0 ν˜
(A1)
0 -0.01% 1.45% 1.45% 94.84% 1.45%
ν˜
(A1,A2,A3)
0 4.31% 1.00% 1.13% 1.32% 4.46%
(g) π∗t (0,X), τ∗t (X) = τ∗t (1,X) = τ∗t (0,X) modeled incorrectly, λ∗1(X) modeled correctly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -1.67% 1.06% 0.99% 64.44% 1.94%
µ˜
(A1,A3)
1 -0.26% 1.61% 1.55% 94.98% 1.57%
µ˜
(A1,A2,A3)
1 -1.86% 1.06% 0.98% 58.50% 2.10%
µ∗0 µ˜
(A1,A2)
0 2.04% 0.99% 1.17% 46.38% 2.35%
µ˜
(A1,A3)
0 -0.27% 1.54% 1.49% 95.34% 1.51%
µ˜
(A1,A2,A3)
0 2.13% 1.01% 1.08% 44.86% 2.39%
ν∗1 ν˜
(A1)
1 -0.02% 1.50% 1.52% 94.54% 1.52%
ν˜
(A1,A2,A3)
1 -1.75% 1.25% 1.06% 73.02% 2.05%
ν∗0 ν˜
(A1)
0 -0.01% 1.44% 1.47% 94.62% 1.47%
ν˜
(A1,A2,A3)
0 1.99% 1.12% 1.13% 57.58% 2.29%
(h) λ∗1(X), π
∗
t (0,X), τ
∗
t (X) = τ
∗
t (1,X) = τ
∗
t (0,X) modeled incorrectly
Parameter Estimator Bias Mean SE SD
95% CI
coverage
√
MSE
µ∗1 µ˜
(A1,A2)
1 -1.66% 1.08% 1.01% 66.22% 1.94%
µ˜
(A1,A3)
1 -7.25% 2.16% 1.74% 5.28% 7.46%
µ˜
(A1,A2,A3)
1 -1.56% 1.07% 1.00% 69.68% 1.85%
µ∗0 µ˜
(A1,A2)
0 2.10% 1.02% 1.22% 46.32% 2.43%
µ˜
(A1,A3)
0 -7.21% 2.07% 1.65% 4.10% 7.40%
ν˜
(A1,A2,A3)
0 1.86% 1.04% 1.11% 58.04% 2.16%
ν∗1 ν˜
(A1)
1 -0.02% 1.53% 1.53% 95.10% 1.53%
ν˜
(A1,A2,A3)
1 4.38% 0.93% 1.03% 0.52% 4.50%
ν∗0 ν˜
(A1)
0 -0.01% 1.47% 1.49% 94.12% 1.49%
ν˜
(A1,A2,A3)
0 6.70% 0.87% 1.14% 0.00% 6.79%
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E R Code
We refer to the data frame for the dataset as datc, let n denote the sample size and let K denote the
number of sample splits. We store the sample split results for each of the five estimators in matrices
named resmua1a2, resmua1a3, resmua1a2a3, resnua1 and resnua1a2a3, respectively. Here is sample R
code.
In the R code, the covariates have the following naming conventions: age (AGE), sex (SEX), high-
est level of education (EDUC), systolic blood pressure (SBP), diastolic blood pressure (DBP), qualifying
symptoms (unstable angina/MI vs. other; ANGTYPE), number of diseased vessels (three vs. less than
three; DISREGB), proximal left anterior descending disease (TSPLADD), prior myocardial infarction (MI),
diabetes (no, with treatment, without treatment; DIAB), current smoking (CIG), hypertension (HYPER). In
addition, R denotes the randomization consent indicator, PTCA denotes the indicator of receiving PTCA
and DEATH denotes the binary indicator of death by the end of 5 years (DEATH).
K=5 # number of sample splits
resmua1a2 = matrix(0,K,4)
resmua1a3 = matrix(0,K,4)
resmua1a2a3 = matrix(0,K,4)
resnua1 = matrix(0,K,6)
resnua1a2a3 = matrix(0,K,6)
sam = sample(1:K,n,replace=TRUE)
for (k in 1: K) {
datmk = datc[sam!=k,] # minus kth split
datk = datc[sam==k,] # kth split
# gam model for death for PTCA patients
# predicted probabilties on minus kth split and kth split
gamyres1mk = gam(DEATH ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (PTCA==1))
pgamyres1mk = predict.Gam(gamyres1mk,datmk,type=’response’)
pgamyres1k = predict.Gam(gamyres1mk,datk,type=’response’)
# gam model for death for CABG patients
# predicted probabilties on minus kth split and kth split
gamyres0mk = gam(DEATH ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (PTCA==0))
pgamyres0mk = predict.Gam(gamyres0mk,datmk,type=’response’)
pgamyres0k = predict.Gam(gamyres0mk,datk,type=’response’)
# gam model for death for PTCA patients in RCT
# predicted probabilties on minus kth split and kth split
gamyres11mk = gam(DEATH ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (R==1 & PTCA==1))
pgamyres11mk = predict.Gam(gamyres11mk,datmk,type=’response’)
pgamyres11k = predict.Gam(gamyres11mk,datk,type=’response’)
# gam model for death for CABG patients in RCT
# predicted probabilties on minus kth split and kth split
gamyres10mk = gam(DEATH ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (R==1 & PTCA==0))
pgamyres10mk = predict.Gam(gamyres10mk,datmk,type=’response’)
pgamyres10k = predict.Gam(gamyres10mk,datk,type=’response’)
# gam model for death for PTCA patients in OBS
# predicted probabilties on minus kth split and kth split
gamyres01mk = gam(DEATH ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (R==0 & PTCA==1))
pgamyres01mk = predict.Gam(gamyres01mk,datmk,type=’response’)
pgamyres01k = predict.Gam(gamyres01mk,datk,type=’response’)
# gam model for death for CABG patients in OBS
# predicted probabilties on minus kth split and kth split
gamyres00mk = gam(DEATH ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (R==0 & PTCA==0))
pgamyres00mk = predict.Gam(gamyres00mk,datmk,type=’response’)
pgamyres00k = predict.Gam(gamyres00mk,datk,type=’response’)
# gam model for enrollment into RCT
# predicted probabilties on minus kth split and kth split
gamrresmk = gam(R ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk)
pgamrresmk = predict.Gam(gamrresmk,datmk,type=’response’)
pgamrresk = predict.Gam(gamrresmk,datk,type=’response’)
# gam model for PTCA in OBS
# predicted probabilties on minus kth split and kth split
gamtres0mk = gam(PTCA ~ SEX + DIAB + MI + HYPER + TSPLADD + CIGB +
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DISREGB + EDUC + ANGTYPE + s(SBPB) +s(DBPB) + s(AGE),
family=binomial, data = datmk, subset = (R==0))
pgamtres0mk = predict.Gam(gamtres0mk,datmk,type=’response’)
pgamtres0k = predict.Gam(gamtres0mk,datk,type=’response’)
# estimated conditional probability of death under PTCA (CABG) given study and covariates
# estimated on minus kth split and kth split
tau1rxmk = pgamyres11mk * (datmk$R==1) + pgamyres01mk * (datmk$R==0)
tau0rxmk = pgamyres10mk * (datmk$R==1) + pgamyres00mk * (datmk$R==0)
tau1rxk = pgamyres11k * (datk$R==1) + pgamyres01k * (datk$R==0)
tau0rxk = pgamyres10k * (datk$R==1) + pgamyres00k * (datk$R==0)
# estimated conditional probability of death under PTCA (CABG) given covariates
# estimated on minus kth split and kth split
tau1xmk = pgamyres1mk
tau0xmk = pgamyres0mk
tau1xk = pgamyres1k
tau0xk = pgamyres0k
# probability of PTCA in RCT for minus kth split and kth split
pi11mk = 0.5
pi11k = 0.5
# marginal probability of study type for minus kth split and kth split
lambda1mk = mean(datmk$R)
lambda1k = mean(datk$R)
# estimated conditional probability of PTCA (CABG) given study and covariates
# estimated on minus kth split and kth split
pi1rxmk = pgamtres0mk * (datmk$R==0) + pi11mk * (datmk$R==1)
pi0rxmk = (1-pgamtres0mk) * (datmk$R==0) + (1-pi11mk) * (datmk$R==1)
pi1rxk = pgamtres0k * (datk$R==0) + pi11mk * (datk$R==1)
pi0rxk = (1-pgamtres0k) * (datk$R==0) + (1-pi11mk) * (datk$R==1)
# estimated conditional probability of PTCA (CABG) given covariates
# estimated on minus kth split and kth split
pi1xmk = pgamrresmk * pi11mk + (1-pgamrresmk) * pgamtres0mk
pi0xmk = pgamrresmk * (1-pi11mk) + (1-pgamrresmk) * (1-pgamtres0mk)
pi1xk = pgamrresk * pi11mk + (1-pgamrresk) * pgamtres0k
pi0xk = pgamrresk * (1-pi11mk) + (1-pgamrresk) * (1-pgamtres0k)
# kth contribution to estimate of mu under Assumptions A1, A2
# kth contribution to standard error calculation
resmua1a2[k,1] = mean((datk$PTCA==1)*(datk$DEATH)/pi1rxk +
(1-(datk$PTCA==1)/pi1rxk)*tau1rxk)
resmua1a2[k,2] = mean((datk$PTCA==0)*(datk$DEATH)/pi0rxk +
(1-(datk$PTCA==0)/pi0rxk)*tau0rxk)
resmua1a2[k,3] = sum(((datk$PTCA==1)*(datk$DEATH)/pi1rxk +
(1-(datk$PTCA==1)/pi1rxk)*tau1rxk-resmua1a2[k,1])^2)
resmua1a2[k,4] = sum(((datk$PTCA==0)*(datk$DEATH)/pi0rxk +
(1-(datk$PTCA==0)/pi0rxk)*tau0rxk-resmua1a2[k,2])^2)
# kth contribution to estimate of mu under Assumptions A1, A3
# kth contribution to standard error calculation
resmua1a3[k,1] = mean((datk$PTCA==1)*(datk$R)*(datk$DEATH)/(pgamrresk*pi11mk) +
(1-(datk$PTCA==1)*(datk$R)/(pgamrresk*pi11mk))*pgamyres11k)
resmua1a3[k,2] = mean((datk$PTCA==0)*(datk$R)*(datk$DEATH)/(pgamrresk*(1-pi11mk)) +
(1-(datk$PTCA==0)*(datk$R)/(pgamrresk*(1-pi11mk)))*pgamyres10k)
resmua1a3[k,3] = sum(((datk$PTCA==1)*(datk$R)*(datk$DEATH)/(pgamrresk*pi11mk) +
(1-(datk$PTCA==1)*(datk$R)/(pgamrresk*pi11mk))*pgamyres11k-resmua1a3[k,1])^2)
resmua1a3[k,4] = sum(((datk$PTCA==0)*(datk$R)*(datk$DEATH)/(pgamrresk*(1-pi11mk)) +
(1-(datk$PTCA==0)*(datk$R)/(pgamrresk*(1-pi11mk)))*pgamyres10k-resmua1a3[k,2])^2)
# kth contribution to estimate of mu under Assumptions A1, A2, A3
# kth contribution to standard error calculation
resmua1a2a3[k,1] = mean((datk$PTCA==1)*(datk$DEATH)/pi1xk +
(1-(datk$PTCA==1)/pi1xk)*tau1xk)
resmua1a2a3[k,2] = mean((datk$PTCA==0)*(datk$DEATH)/pi0xk +
(1-(datk$PTCA==0)/pi0xk)*tau0xk)
resmua1a2a3[k,3] = sum(((datk$PTCA==1)*(datk$DEATH)/pi1xk +
(1-(datk$PTCA==1)/pi1xk)*tau1xk-resmua1a2a3[k,1])^2)
resmua1a2a3[k,4] = sum(((datk$PTCA==0)*(datk$DEATH)/pi0xk +
(1-(datk$PTCA==0)/pi0xk)*tau0xk-resmua1a2a3[k,2])^2)
# kth contribution to estimate of nu under Assumption A1
# kth contribution to standard error calculation
resnua1[k,1] = mean(datmk$R*pgamyres11mk/lambda1mk)
resnua1[k,2] = mean(datmk$R*pgamyres10mk/lambda1mk)
resnua1[k,3] = resnua1[k,1] +
mean((datk$PTCA==1)*(datk$R)*(datk$DEATH)/(lambda1mk*pi11mk) +
datk$R/lambda1mk * (1-(datk$PTCA==1)/pi11mk)*pgamyres11k -
datk$R/lambda1mk*resnua1[k,1])
resnua1[k,4] = resnua1[k,2] +
mean((datk$PTCA==0)*(datk$R)*(datk$DEATH)/(lambda1mk*(1-pi11mk)) +
datk$R/lambda1mk * (1-(datk$PTCA==0)/(1-pi11mk))*pgamyres10k -
datk$R/lambda1mk*resnua1[k,2])
resnua1[k,5] = sum(((datk$PTCA==1)*(datk$R)*(datk$DEATH)/(lambda1mk*pi11mk) +
datk$R/lambda1mk * (1-(datk$PTCA==1)/pi11mk)*pgamyres11k -
datk$R/lambda1mk*resnua1[k,3])^2)
resnua1[k,6] = sum(((datk$PTCA==0)*(datk$R)*(datk$DEATH)/(lambda1mk*(1-pi11mk)) +
datk$R/lambda1mk * (1-(datk$PTCA==0)/(1-pi11mk))*pgamyres10k -
datk$R/lambda1mk*resnua1[k,4])^2)
# kth contribution to estimate of nu under Assumptions A1, A2, A3
# kth contribution to standard error calculation
resnua1a2a3[k,1] = mean(pgamrresmk*tau1xmk/lambda1mk)
resnua1a2a3[k,2] = mean(pgamrresmk*tau0xmk/lambda1mk)
resnua1a2a3[k,3] = resnua1a2a3[k,1] +
mean((datk$PTCA==1)*pgamrresk*(datk$DEATH)/(lambda1mk*pi1xk) +
(datk$R-(datk$PTCA==1)*pgamrresk/pi1xk)*tau1xk/lambda1mk -
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datk$R/lambda1mk*resnua1a2a3[k,1])
resnua1a2a3[k,4] = resnua1a2a3[k,2] +
mean((datk$PTCA==0)*pgamrresk*(datk$DEATH)/(lambda1mk*(1-pi1xk)) +
(datk$R-(datk$PTCA==0)*pgamrresk/(1-pi1xk))*tau0xk/lambda1mk -
datk$R/lambda1mk*resnua1a2a3[k,2])
resnua1a2a3[k,5] = sum(((datk$PTCA==1)*pgamrresk*(datk$DEATH)/(lambda1mk*pi1xk) +
(datk$R-(datk$PTCA==1)*pgamrresk/pi1xk)*tau1xk/lambda1mk -
datk$R/lambda1mk*resnua1a2a3[k,3])^2)
resnua1a2a3[k,6] = sum(((datk$PTCA==0)*pgamrresk*(datk$DEATH)/(lambda1mk*(1-pi1xk)) +
(datk$R-(datk$PTCA==0)*pgamrresk/(1-pi1xk))*tau0xk/lambda1mk -
datk$R/lambda1mk*resnua1a2a3[k,4])^2)
}
# Estimates, standard errors and confidence intervals of mu, nu
mua1a2 = apply(resmua1a2,2,mean)[1:2]
semua1a2 = sqrt(apply(resmua1a2,2,sum)/n^2)[3:4]
lcimua1a2 = mua1a2 - 1.96*semua1a2
ucimua1a2 = mua1a2 + 1.96*semua1a2
mua1a3 = apply(resmua1a3,2,mean)[1:2]
semua1a3 = sqrt(apply(resmua1a3,2,sum)/n^2)[3:4]
lcimua1a3 = mua1a3 - 1.96*semua1a3
ucimua1a3 = mua1a3 + 1.96*semua1a3
mua1a2a3 = apply(resmua1a2a3,2,mean)[1:2]
semua1a2a3 = sqrt(apply(resmua1a2a3,2,sum)/n^2)[3:4]
lcimua1a2a3 = mua1a2a3 - 1.96*semua1a2a3
ucimua1a2a3 = mua1a2a3+ 1.96*semua1a2a3
nua1 = apply(resnua1,2,mean)[3:4]
senua1 = sqrt(apply(resnua1,2,sum)/n^2)[5:6]
lcinua1 = nua1 - 1.96*senua1
ucinua1 = nua1 + 1.96*senua1
nua1a2a3 = apply(resnua1a2a3,2,mean)[3:4]
senua1a2a3 = sqrt(apply(resnua1a2a3,2,sum)/n^2)[5:6]
lcinua1a2a3 = nua1a2a3 - 1.96*senua1a2a3
ucinua1a2a3 = nua1a2a3 + 1.96*senua1a2a3
# Estimates, standard errors and confidence intervals of treatment effects
deltamua1a2 = mua1a2[1]-mua1a2[2]
sedeltamua1a2 = sqrt(sum(semua1a2^2))
cideltamua1a2 =c(deltamua1a2-1.96*sedeltamua1a2,
deltamua1a2+1.96*sedeltamua1a2)
deltamua1a3 = mua1a3[1]-mua1a3[2]
sedeltamua1a3 = sqrt(sum(semua1a3^2))
cideltamua1a3 =c(deltamua1a3-1.96*sedeltamua1a3,
deltamua1a3+1.96*sedeltamua1a3)
deltamua1a2a3 = mua1a2a3[1]-mua1a2a3[2]
sedeltamua1a2a3 = sqrt(sum(semua1a2a3^2))
cideltamua1a2a3 =c(deltamua1a2a3-1.96*sedeltamua1a2a3,
deltamua1a2a3+1.96*sedeltamua1a2a3)
deltanua1 = nua1[1]-nua1[2]
sedeltanua1 = sqrt(sum(senua1^2))
cideltanua1 =c(deltanua1-1.96*sedeltanua1,
deltanua1+1.96*sedeltanua1)
deltanua1a2a3 = nua1a2a3[1]-nua1a2a3[2]
sedeltanua1a2a3 = sqrt(sum(senua1a2a3^2))
cideltanua1a2a3 =c(deltanua1a2a3-1.96*sedeltanua1a2a3,
deltanua1a2a3+1.96*sedeltanua1a2a3)
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